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ABSTRACT 
A marker system based on the presence or absence epitopes of the N, M, GPS and 
GPS proteins of porcine reproductive and respiratory syndrome (PRRS) virus was developed 
for use in epidemiological studies. Mxirine monoclonal antibodies (MAbs) were generated 
that represented; 7 continuous and 3 discontinuous epitopes of the N protein and were 
designated EpORF7-A through Hd; 3 discontinuous epitopes of the M protein designated 
EpORF6-Ad, Bd and Cd; 3 continuous epitopes of GPS designated EpORFS-A, B and C; and 
2 continuous epitopes of GP3 designated EpORF3-A and B. Monoclonal antibodies 
representing EpORF5-C and EpORF6-Ad and Bd had neutralizing activity. Epitope profiles 
were determined for 69 North American (NA) PRRS viruses and the Lelystad virus using a 
panel of MAbs that represented the 18 epitopes. The 69 NA viruses were categorized first 
into 5 major antigenic groups designated lis through IV15 and VI15 based on the N protein. 
These 5 groups represented 82.6, 11.6, 2.9, 1.4 and 1.4% of all NA viruses respectively. The 
European Lelystad virus constituted a separate antigenic group designated V15. Groups lis. 
Ills, and niis were subsequently categorized into 9,4 and 2 subgroups based on sero-
reactivity with MAbs representing specific epitopes of the M, GP3 and GPS proteins. Groups 
rVi5 and Vis each represented a single virus. The stability of each of the above 18 epitopes 
was evaluated for stability by serially passaging and maintaining S NA isolates in pigs in 3 
separate experiments for periods ranging fix>m 16 to 22 weeks. No differences were 
observed in the epitope profile of any of these 5 viruses following passage. Preliminary 
studies were also undertaken to identify the region of ORF 7 that encode specific epitopes. 
Analysis of the amino acid sequence of the N protein using the GCG package and blocking 
xi 
assays suggested that EpORF7-B, C, and D are located close to one another between position 
70 and 122 and that EpORF7-A and E are spatially distant from each other and EpORF7-B, 
C and D. 
I 
GENERAL INTRODUCTION 
Introduction 
The porcine reproductive and respiratory syndrome (PRRS) is an economically 
significant viral disease of swine. The disease is characterized by late-term abortions in 
sows, stillborn and weak piglets at birth, and increased mortality rates in weaned pigs (Goyal, 
1993). 
The PRRS virus is a single-stranded, positive-sense RNA virus and belongs to the 
fdimly Arteriviridae (Cavanagh, 1997; Pringle, 1996). The genome of PRRS virus encodes 6 
structural proteins with molecular masses of 15,19,25, 30, 31 and 45 kD that are designated 
N, M, GP2 through 5 (Conzelmann et al., 1993; Meulenberg and Petersen-Den Besten, 1996; 
Meulenberg et al., 1993a; 1995; Van Nieuwstadt et al., 1996). After PRRS viruses were 
isolated from pigs, antigenic variability was demonstrated between European and North 
American viruses (Wensvoort et al., 1992a). Since then, both genetic and antigenic 
differences have been repeatedly demonstrated between and among European and North 
American PRRS viruses by comparing nucleotide sequences (AUende et al., 1999; Andreyev 
et al., 1997, Drew et al., 1997; Kapur et al., 1996; Le Gall et al., 1998; Mardassi et al., 1995; 
Meng et al. 1995; Murtaugh et al., 1995; Su^ez et al., 1996; Wesley et al., 1998) and sero-
reactivity with monoclonal antibodies (Dea et al., 1996; Drew et al., 1995; Le Gall et al., 
1997; Magar et al. 1997; Nelson et al., 1993; Pirzadeh and Dea, 1997; Rodriguez et al., 1997; 
Van Nieuwstadt et al., 1996; Wieczorek-Krohmer et al., 1996; Yoon et al., 1995; Zhang et 
al., 1998). The extent and dynamics of this variability in genetic and antigenic characteristics 
of PRRS viruses are of particular importance with respect to development of a universal 
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diagnostic test, effective vaccines and control procedures. For example, there is evidence 
that failure to prevent and control PRRS using management protocols with or without 
vaccine may be due to antigenic/genetic variability between field viruses (Mengeling et al., 
1998). Accordingly, the primary objective of this study was to develop a virus maricer 
system for epidemiological studies based on the presence or absence of epitopes. This 
marker system could be used to determine if a coirelation exists between specific viruses and 
success or failure of specific management strategies, and monitor movement of PRRS virus 
within and between geographical regions. Consequently, a panel of MAbs specific for North 
American PRRS viruses was developed and the in vivo stability of the epitopes represented 
by these MAbs was evaluated. A secondary objective of this study was to identify the 
regions within open reading frames that encode specific epitopes. 
Dissertation Organization 
This dissertation is organized into S chapters. The first chapter contains the general 
introduction and the literature review. Three papers that represent the experimental studies 
are presented in the second, third and fourth chapters. The doctoral candidate is the principal 
investigator and senior author for all of the three papers. The first paper, "Antigenic and 
genetic variations of the 15 kD nucleocapsid protein of porcine reproductive and respiratory 
syndrome virus isolates," was published in the Archives of Virology, 1999, 144: 525-546. 
The second paper, "Categorization of North American porcine reproductive and respiratory 
syndrome viruses: Epitopic profiles of the N, M, GP5 and GPS proteins and susceptibility to 
neutralization," is in press in the Archives of Virology. The third paper, "Stability of epitope 
profiles of North American porcine reproductive and respiratory syndrome viruses during 
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serial passage in pigs," will be submitted to the Journal of General Virology. The last 
chapter contains the general conclusions of the research studies. 
Literature Review 
History of PRRS 
The porcine reproductive and respiratory syndrome (PRRS) was first reported as 
devastating outbreaks of reproductive failure in North Carolina, Minnesota, and Iowa in the 
United States during 1987 and 1988 (Hill, 1990; Keffaber, 1989). In the years following, 
PRRS spread throughout the United States and Canada (Hill, 1990). In 1990, the disease was 
first recognized in Germany and soon afterwards in several other Western European 
countries (Wensvoort, 1993). Presently, PRRS is endemic in most swine-producing 
countries throughout the world. 
The PRRS virus was first isolated in Europe by Wensvoort et al. (1991) using porcine 
alveolar macrophages (PAMs) and designated the Lelystad virus. Subsequently, Benfield et 
al. (1992) and Collins et al. (1992) isolated a PRRS virus fix)m North American swine using 
the proprietary continuous cell line CL2621 and designated it ATCC VR-2332. 
Before the PRRS virus was isolated and confirmed as the etiological agent of the 
syndrome, a number of different microbial organisms were implicated as the cause of PRRS. 
These agents included porcine parvovirus, pseudorabies virus, leptospira, porcine 
enteroviruses, encephalomyocarditis virus, hog cholera virus, mycoplasma, swine influenza 
virus, paramyxovirus. Chlamydia psittaci, and Streptococcus suis, all of which were isolated 
fi-om suspected PRRS cases (Bilodeau et al., 1991; Christianson, 1992; Dea et al., 1992; 
Loula, 1991; Meredith, 1992; Paton et al., 1991; Wensvoort et al., 1991). 
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Initially, many names were used to describe the syndrome. These names included; 
mystery swine disease (MSD) (Wensvoort et al., 1991), blue eared pig disease (White, 1991), 
porcine epidemic abortion and respiratory syndrome (PEARS) (Pol et al., 1991; Terpstra et 
al., 1991), or swine infertility and respiratory syndrome (SIRS) (Benfield et al., 1992; Collins 
et al., 1992; Morrison et al, 1992; Yoon et al., 1992a; 1992b). 
With the discovery of the PRRS virus, the ofiBcial name of the syndrome was 
designated as the Porcine Reproductive and Respiratory Syndrome (PRRS). This 
nomenclature was officially presented at the First International Symposium on SIRS/PRRS 
held in St. Paul, Minnesota in 1992 (Meredith, 1993). 
Clinical manifestations 
The clinical signs of pigs infected with PRRS virus are highly variable and depend on 
a number of factors including age of the pigs, health status, management practices, immune 
status, and reproductive status. The onset of the disease in sows is often marked by 
depression, lethargy, anorexia and pyrexia. Periocular edema and conjunctivitis are seen in 
some pigs. Some sows show respiratory symptoms whereas others have slightly elevated 
body temperatures; however, reproductive failure occurs in all parities. Pregnant sows abort 
at late-term of gestation (days 107-112) or deliver high numbers of stillborn, mummified or 
weak piglets that die shortly after birth or grow poorly. The herd abortion rate ranges from 1 
to 3% (Hopper et al., 1992; White 1992). The mortality rate of acutely ill sows ranges from 
1 to 4% (Loula, 1991). Clinical signs of infected boars include anorexia, fever and 
inappetence. The semen quality of infected boars is also low (Benfield et al., 1999). 
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Respiratory disease is the major clinical manifestation of PRRS in weaned piglets in 
the nurseiy. Affected piglets show a short period of anorexia and mild fever. Piglets bom to 
infected sows often develop severe respiratory disease within 4-8 weeks (Meredith, 1995). 
Secondary infections with swine influenza virus, paramyxovirus. Chlamydia psittaci. 
Mycoplasma hyopneumoniae. Streptococcus suis, Actinobacillus pluropneumoniae. 
Hemophilus parasuis and Pasteurella multocida are common. 
A wide range of variation in the severity of PRRS infection is commonly observed in 
both breeding animals and in young pigs. While variations in severity may be influenced by 
management factors and coinfection with other swine pathogens, such as mycoplasmas 
(Thacker et al., 1999), variation in severity may also be due to strain differences among 
PRRS viruses as illustrated by the emergence of highly severe clinical manifestations of 
PRRS in 1996 (Epperson and Holler, 1997; Halbur and Bush, 1997; Htird et al., 1998; Joo et 
al., 1998a; Mengeling et al., 1997; Rossow, 1997; Zimmerman et al., 1997). The apparent 
increase in severity of PRRS infection in these herds led to the use of the term "atypical" or 
"acute" PRRS to describe these severe clinical manifestations. These cases are defined by 
acute onset, persistence of clinical signs over a 2-4 week period, herd case mortality rates as 
high as 5% in sows and boars, and herd abortion rates as high as 10% in all parities and in all 
stages of gestation (Zimmerman et al., 1997). 
Differences in virulence between PRRS viruses isolated from herds with both 
traditional and atypical manifestations have been demonstrated in controlled experiments. 
Mengeling et al. (1998) inoculated 2 pregnant gilts oronasally at 90 days of gestation with 
each of 4 different PRRS viruses. Each gilt received 10 ml of cell ctilture medium containing 
10® TCIDso/ml of the selected PRRS virus. These viruses were isolated from 4 separate 
6 
herds. Abortion occurred in 10 out of200 sows in herd 1, in 200 out of2000 sows in herd 2, 
and in 80, 130,500 and 650 out of2000 sows in 4 gestation buildings in herd 3. In herd 4 
with 11 GO sows, 700 sows aborted and 85-100 pregnant sows died. Although all of the 4 
viruses caused reproductive failure in pregnant gilts, the virus that was isolated from herd 4 
caused complete loss of fetuses and severe clinical disease. Each of the 4 viruses was also 
inoculated into 2 pregnant gilts at 45 days of gestation as mentioned above. Four mummified 
fetuses were delivered by the 2 gilts that were exposed to the virus from herd 4. No 
reproductive problems were observed in gilts that were exposed to the other 3 viruses. 
The severity in virulence of atypical PRRS virus was also demonstrated by other 
investigators. Lager et al. (1998) inocxilated 8 pregnant gilts oronasally at 85-89 days of 
gestation with "liver homogenate" derived from a sow with "atypical PRRS". All of the 8 
gilts developed anorexia, pyrexia and depression. Two gilts aborted at 107 and 109 days of 
gestation whereas five gilts farrowed between 112 and 125 days of gestation. One gilt died 
at 16 days post-inoculation. A total 8 live piglets were delivered. 
Halbur et al. (1998) inoculated seven 3-week-old cesarean-derived, colostrum-derived 
(CDCD) piglets oronasally with "liver homogenate" derived from a sow with "atypical 
PRRS". The piglets developed severe respiratory disease. Three out of 7 piglets developed 
icterus. The liver homogenate from these affected piglets was inoculated into an additional 
thirty-six 3-week-old CDCD piglets. The animals exhibited respiratory disease, persistent 
fever and lethargy. Severe lung and liver lesions and lymphadenopathy were observed at 
necropsy. These studies led to the conclusion by Mengeling et al. (1998) that highly virulent 
PRRS viruses circulate among U.S. herds. 
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Porcine reproductive and respiratory syndrome virus 
The porcine reproductive and respiratory syndrome virus is a member of the family 
Arteriviridae of \hc order Nidovirales 1997; Pringle, 1996). Lactate 
dehydrogenase-elevating virus (LDV) of mice, equine arteritis virus (EAV) and simian 
haemorrhagic fever virus (SHFV) are also members of this family (Cavanagh, 1997; Pringle, 
1996). 
The porcine reproductive and respiratory syndrome virus is an enveloped virus. The 
virus is 45-83 nm in diameter and contains a cubical nucleocapsid core of25-35 nm in 
diameter (Benfield et al., 1992; Botner et al., 1994; Kuwahara et al., 1994; Mardassi et al., 
1994a; Onlinger et al., 1991; Pol and Wagenaar, 1992; Wensvoort, 1993; Wensvoort et al., 
1991). The buoyant density of the virus is 1.13-1.19 g / ml in cesium chloride and 1.18-1.23 
g / ml in sucrose (Bautista et al., 1996; Benfield et al., 1992; Christianson and Joo, 1994; 
Mardassi et al., 1994a; Meng et al., 1994; Wensvoort et al., 1991; 1992b). 
The virus loses its infectivity when treated for 15-20 minutes at 56 °C, 10-24 hours at 
37 °C, 6 days at 20 °C and over 1 month at 4 °C. Infectivity can be maintained for at least 18 
months at -70 °C (Benfield et al., 1992; Yoon et al., 1992a). The virus infectivity titers are 
reduced over 90% at a pH less than 5 or greater than 7 (Benfield et al., 1992). In culture 
media, at pH 7.5, the half-life of the Lelysatd virus was estimated to be 0.1, 3, 20 and 140 
hours at 56, 37, 21, and 4 °C respectively ( Bloemraad et al., 1994). 
The virus does not hemagglutinate swine, sheep, goat, cattle, moiise, rat, rabbit, 
guinea pig, hmnan type O, duck or chicken erythrocytes (Benfield et al., 1992; Meng et al., 
1996; Wensvoort et al., 1991; 1992b). However, Jusa et al. (1996) observed that cell-fi*ee 
and cell-associated PRRS viruses hemagglutinated mouse erythrocytes. The 
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hemagglutination inhibition titers of pig sera showed a positive correlation with 
neutralization titers. Pretreatment of the virus with Tween 80 and ether greatly increased 
hemagglutination. Moreover, Jusa et al. (1997a) found that the hemagglutinin activity 
peaked at 1.17 g /cm^ in cesium chloride gradient centrifiigation. The hemagglutinin peak 
fraction was demonstrated in the SDS-PAGE to be composed of the N protein. 
The porcine reproductive and respiratory syndrome virus can grow in PAMs 
(Wensvoort et al., 1991) and the African green monkey kidney cell line MARC-104 and a 
subpopulation of this cell line that has been designated MARC-145 cells (Kim et al., 1993). 
The proprietary cell lines CL2621 (Benfield et al., 1992) and CRLl 1171 (Meng et al., 1996) 
also support the virus growth. Voicu et al. (1994) reported that peripheral blood monocytes 
can be infected with PRRS virus. In addition, Molitor et al. (1997) and Thanawongnuwech 
et al. (1997) reported that spleen macrophages, brain microglial cells and porcine 
intravascular macrophages (PIMs) also supported replication of the virus in vitro. Sur et al. 
(1997) also reported that the virus replicated in testicular germ cells such as spermatids and 
spermatocytes in infected boars. Some viruses replicated in PAMs only or in CL2621 only 
but not in both cell types (Bautista et al., 1993a). A variety of other cell lines of animal 
origin such as PK-2, PK-15 and SK-6, were tested but none of them was permissive for virus 
replication (Benfield et al., 1992; Meng et al., 1996; Wensvoort et al., 1991). 
The cell tropism may be determined by the presence or absence of receptors on the 
cell surface. Meulenberg et al. (1998) found that BHK-21 cells could support gene 
expression of PRRS virus when infectious cDNA was introduced by transfection. Either 
treatment of virus with heparin or of MARC-145 cells with heparinase blocked virus 
infection, suggesting that a heparin-like molecule is associated with the virus attachment 
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process (Jusa et al., 1997b). Duan et al. (1998) reported that a 210 kD membrane protein on 
the surface of PAMs might serve a putative receptor for PRRS virus because MAbs specific 
for this protein blocked virus attachment to PAMs. This protein is ^patently not present on 
MARC-145 cell membranes because the same panel of MAbs did not interfere with virus 
attachment to MARC-145 cells. This observation suggests that one or more different 
receptors are used for virus attachment to MARC-145 cells. Porcine reproductive and 
respiratory syndrome virus enters permissive cells through receptor mediated endocytosis 
and the completion of the penetration process is low pH dependent (Kreutz and Ackermann, 
1996; Nauwynck et al., 1999). 
The presence and extent of the cytopathic effect (CPE) depend on cell types and 
viruses. The CPE in PAMs is observed 1-4 days after infection. Infected cells round up and 
clump together (Wensvoort et al., 1991). The virus titer in PAMs ranges between 10^-10^"® 
TCEDso/ml (Bloemraad et al., 1994; Christianson and Joo, 1994; Meng et al., 1996; 
Wensvoort et al., 1992b; Wensvoort, 1993). The CPE appears 2-6 days after infection in 
CL2621 and MARC-145 cells, and is characterized by roimding and climiping of cells 
followed by pyknosis and detachment (Benfield et al., 1992; Kim et al., 1993). The virus 
titers in CL2621 and MARC-145 cells can reach to lO' TCIDso/ml (Benfield et al., 1992) and 
10® TCIDso/ml (Kim et al., 1993) in standard cell cvdture containers, respectively. In 
contrast, some viruses are not highly cytopathic and do not form extensive CPE even if 
incubation time is extended. A few viruses do not form visible CPE in PAMs or MARC-145 
cells. The presence of these non-cytopathic viruses in cell cultures can be demonstrated by 
the EFA test (Frey, 1999). 
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The genome of the arteriviruses is a single strand of positive sense RNA that varies 
from 12.7 to 15.7 kb in size (Snijder and Meulenberg, 1998). The genomic organization of 
the arteriviruses was first described for EAV by Den Boon et al. (1991) who identified the 
presence of a nested set of 8 open reading firames (ORFs). More recently, a region between 
ORF lb and ORf 2 of the EAV genome that encodes a 67 amino acid structural protein has 
been identified (Snijder et al., 1999). This region of the EAV genome has been designated 
ORF 2a and the former ORF 2 has been renamed ORF 2b. The viruses in the Arteriviridae 
are similar with respect to genome organization, replication strategy, expression of proteins, 
establishment of persistent infection and preference for infection of macrophages both in 
vitro and in vivo (Snijder and Meulenberg, 1998). 
The genome of the European Lelystad virus is a polyadenylated RNA molecule of 
about 15 kb and contains 8 open reading firames (ORFs). These ORFs are designated la, lb, 
and 2 through 7 (Meulenberg et al., 1993a). An additional ORF equivalent to ORF 2a of 
EAV may also exist in the PRRS virus genome (Snijder et al., 1999). The complete 
nucleotide sequence of the European Lelystad virus was determined in 1993 (Meulenberg et 
al., 1993a). The ORFs la and lb account for 75% of the whole genome and encode a viral 
replication-related enzyme. The other 6 ORFs account for 25% of the genome. The ORFs 2 
to 5 encode 4 envelope-associated proteins with molecular masses of 30, 45, 31 and 25 kD 
respectively. These 4 envelope proteins are glycosylated and are designated GP2 through 
GP5 (Van Nieuwstadt et al., 1996). The GP2 and GPS proteins are counterparts of the Gs 
and GL proteins of EAV (De Vries et al., 1992; Snijder and Meulenberg, 1998). The ORF 6 
encodes an imglycosylated, matrix (M) protein with a molecular mass of 19 kD. The ORF 7 
encodes the nucleocapsid (N) protein with a molecular mass of 15 kD. The GP4 and GP5 
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proteins induce neutralizing antibodies (Gonin et al., 1999; Meulenberg et al., 1997; Persch 
et al., 1995; Pirzadeh and Dea, 1997; Van Nieuwstadt et al., 1996; Weiland et al., 1999; 
Zhang et al., 1998). 
The ORFs 2 to 7 are overlapping and are expressed from 6 subgenomic RNAs 
(Conzelmann et al., 1993; Meulenberg et al., 1993a). These subgenomic RNAs form a 3' co-
terminal nested set and are composed of a common leader sequence, which is derived from 
the 5' end of the viral genome (Conzelmaim et al., 1993; Meulenberg et al., 1993b). The 
open reading frames (ORFs) 2 through 7 and encoded proteins of the Lelystad virus are 
depicted in Table 1. 
Table 1. The open reading frames (ORFs) 2 through 7 and encoded proteins of the 
Lelystad virus 
ORF Size No. of Calculated N-glycosylation Signal 
Putative 
transmembrane 
region 
Molecular weight^ 
(kb) amino acids MW* sites'* sequence' In vitro In vivo 
2 3.7 249 28.4 2 37-38 210-228 30 nd 
3 3.1 265 30.6 7 41-42 nd' 45 nd 
4 2.6 183 20.0 4 nd 1-17/165-183 31 nd 
5 2.0 201 22.4 2 32-33 108-131 25 25 
6 1.4 173 18.9 2 nd 17-88 18 18 
7 0.9 128 13.8 1 nd nd 15 15 
(Modified from Conzelmann et al., 1993 and Meulenberg et al., 199S.) 
' Calculated molecular weight (kD) on the basis of the amino acid sequence. 
'' Number of putative N-glycosylation sites. 
' Amino acid position of the putative signal sequence cleavage site. 
MW (kD) on SDS-PAGE of the gene products of the ORFs expressed in in vitro and in vivo. 
' nd, not determined. 
Genetic variability 
Analyses of the nucleotide sequences of PRRS viruses indicate that European and 
North American PRRS viruses represent 2 distinct genotypes that emerged from a common 
precursor (Allende et al., 1999; K^ur et al., 1996; Kwang et al., 1994; Le Gall et al., 1998; 
Mardassi et al., 1994b; 1994c; 1995; Meng et al., 1994; 1995; Muitaugh et al., 1995). The 
differences in the number and percentage identity of nucleotides and deduced amino acids 
between representative PRRS viruses of European and North American origins are 
summarized in Tables 2 and 3. 
The European PRRS viruses are genetically variable. The identity of deduced amino 
acid sequences between the Lelystad virus and the European virus 10 varied from 99 to 
100% among ORFs 2 through 7 (Conzelmann et al., 1993; Meulenberg, 1998b). Suarez et al. 
(1996) analyzed the nucleotide sequences of the complete ORF 5 of 15 European PRRS 
viruses including the Lelystad virus. The nucleotide identity of ORF 5 of these viruses 
ranged from 87.1 to 99.2%. Analysis of the partial nucleotide sequences of ORF 7 of these 
viruses revealed a higher identity, i.e., 94.1- 99.6%. Drew et al. (1997) compared the 
nucleotide sequences and deduced amino acids of ORFs 3, 4 and 7 of 8 European PRRS 
viruses including the Lelystad virus. The average percent identity of nucleotide sequences of 
ORFs 3, 4 and 7 ranged from 96.4 to 99.7% and the percent identity of deduced amino acid 
sequences ranged from 92.5 to 99.2%. Le Gall et al. (1998) compared the nucleotide 
sequences of ORF 7 of 15 European PRRS viruses. The identity of deduced amino acid 
sequences varied from 97.7 to 100%. These restilts indicate that genetic variation exists 
among European PRRS viruses. However, this variation appears to be relatively low. 
13 
Table 2. The numbers of nucleotides and deduced amino acids of the European and North 
American porcine reproductive and respiratory syndrome viruses 
^ J - r- , ^ • European viruses North American viruses Open reading frame / protein i j / • -j i 
nucleotide / ammo acid nucleotide / anuno acid 
2/GP2 750 / 249 771 /256 
3/GP3 798 / 265 765 / 254 
4/GP4 552/ 183 537/ 174 
5/GPS 606 / 201 603 / 200 
6 / M  5 2 2 /  1 7 3  5 2 5 /  1 7 4  
7 / N  3 8 7 / 1 2 8  3 7 2 /  1 2 3  
Table 3. The percent identity of the deduced amino acid sequences of proteins encoded by 
open reading frames (ORFs) 2 through 7 of the Lelystad virus with the European 
PRRS virus 10 and 4 North American PRRS viruses 
Open reading frame / 
protein 
PRRS 
virus 10* 
ATCC 
VR-2332'' 
ATCC 
VR-2385^ 
PRRS virus 
16244B'* 
PRRS virus 
IAF-exp91' 
2/GP2 99 63 nd 62 nd 
3 /GP3 99 58 nd 60 54 
4/GP4 99 68 nd 66 68 
5/GP5 99 59 54 58 52 
6 / M  100 78 78 79 81 
7 / N  100 65 58 60 59 
^ Conzelmann et al. (1993) and Meulenberg (1998b) 
Murtaugh et al. (1995) 
Meng et al. (1994) 
Allende et al. (1999) 
' Mardassi et al. (1995) 
nd, not detennined 
Genetic variability also exists among North American PRRS viruses. Meng et al. 
(1995) compared the nucleotide sequences of ORFs 6 and 7 of 8 North American PRRS 
viruses including ATCC-VR-2332 and ATCC VR-2385. Comparisons of both ORF 6 and 7 
of these PRRS viruses revealed 96-100% amino acid identity. Kapur et al. (1996) analyzed 
genetic variability among 10 midwestem U. S. PRRS viruses. The average nucleotide 
identity of these viruses ranged varied from 92.1 to 97.5%. Andreyev et al. (1997) analyzed 
the nucleotide sequences and deduced amino acids of ORF 5 of 24 North American PRRS 
viruses including ATCC-VR-2332 and ATCC VR-2385. These viruses had 91-95% 
nucleotide and 89-94% deduced amino acid sequence identity respectively. Le Gall et al. 
(1998) demonstrated a 93.5 to 100% identity of the deduced amino acid sequences encoded 
by ORF 7 of 13 North American PRRS viruses including ATCC VR-2332 and IAF-exp91. 
Unique genetic differences have also been demonstrated between North American 
and European PRRS viruses. The identity of deduced amino acid sequences between the 
Leiystad virus and 4 North American viruses (ATCC VR-2332, ATCC VR-2385, IAF-exp91, 
and 16244B) was low, i.e., 62-63% in 0RF2, 54-60% in ORF3, 66-69% in ORF4, 52-59% in 
0RF5, 78-81% in ORF6, and 59-65% in ORF7 (Allende et al., 1999; Mardassi et al., 1995; 
Meng et al., 1994; Murtaugh et al., 1995). 
Genetic variation among North American PRRS viruses and European PRRS viruses 
is characterized by random nucleotide substitutions. Genetic variation between North 
American and European viruses is characterized by nucleotide additions or deletions as 
illustrated in Table 2. According to Nelson et al. (1999) who compared the entire genomes 
of PRRS viruses ATCC VR-2332 and the Leiystad virus. North American and European 
viruses evolved independently from a common precursor. Nelson et al. (199) also speculated 
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that the simultaneous emergence of a similar disease on the two continents was due primarily 
to changes in animal husbandry and management. 
The genetic heterogeneity of PRRS viruses can be expected to increase with 
international movement of swine and the use of modified-live vaccines. Such heterogeneity 
can be the result of quasispecies (Holland et al., 1992) emerging in response to 
immunological pressure of vaccine usage, or a result of natural mutations (Palese, 1993) and 
recombination. For example, Le Gall et al. (1997) observed the loss and gain of a specific 
epitope of GP3 in 2 different PRRS viruses during maintenance in pigs (see page 28 of this 
review). Similarly, Rowland et al. (1999) demonstrated a unique nucleotide substitution in 
the first 215 nucleotides of ORF 5 of ATCC VR-2332 following virus passage in 3 pigs that 
were infected in utero. This nucleotide substitution resulted in a deduced amino acid change 
fi-om aspartic acid to asparagine. No changes were observed in the last 312 nucleotides of 
ORF 4 and a 10 nucleotide untranslated region. These observations by Le Gall et al. (1997) 
and Rowland et al. (1999) suggest that some areas of the PRRS virus genome are more 
susceptible to mutation than others. 
Recombination between PRRS viruses has been demonstrated in vitro. Yuan et al. 
(1999) reported a recombination between the ORFs 3 and 4 of the modified-live vaccine 
viruses RespPRRS and Prime Pac PRRS in co-infected MA-104 cells. Similar 
recombination events involving other ORFs can be expected to occur in the field. For 
example, Kapur et al. (1996) analyzed 611 polymorphic nucleotide sites in ORFs 2 through 7 
of 10 midwestem U.S. PRRS viruses and suggested that intragenic recombination might 
occur in all of these ORFs except ORF 6. 
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Antigenic variability 
The first evidence of antigenic variation among and between North American and 
European PRRS viruses was provided by Wensvoort et al. (1992a). These investigators 
compared the titers of 11 swine sera representing S different European countries and 13 sera 
representing the United States and Canada. Titers were determined by the 
immimoperoxidase monolayer assay (IPMA) using 3 North American viruses and 4 
European viruses as antigen. A similar observation was made when 214 swine sera from 
Canada were tested for the presence of PRRS virus antibody in the indirect fluorescence 
assay (IFA) using ATCC VR-2332 and Lelystad virus infected MA-104 cells as antigen 
(Frey et al., 1992). Bautista et al. (1993b) also conducted a study that revealed differences in 
sero-reactivity of the Lelystad vims and ATCC VR-2332 with swine sera. A subsequent 
study by Bautista et al. (1994) which utilized swine sera raised against ATCC VR-2332, MN-
18 and the Lelystad virus further revealed the existence of antigenic variation among 20 
PRRS viruses which included ATCC VR-2332 and the Lelystad virus. Varying 
susceptibility of field PRRS viruses to neutralization mediated by swine sera was also 
demonstrated by Yoon et al. (1994) and Yoon et al. (1997). Antigenic variation between and 
among North American and European PRRS viruses has also been demonstrated by using 
monoclonal antibodies (MAbs) specific for structural proteins as described below in this 
review. 
N protein 
The N protein is associated with the nucleoc^sid suiroimding the virus genome. The 
N protein is a basic protein as it does not contain hydrophobic amino acid sequences 
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(Meulenberg et al., 1995). As has been revealed by the appearance and multitude of antibody 
specific for this protein (Nelson et al., 1994; Yoon et al., 1995a), the N protein is strongly 
immunogenic. Hence, the majority of MAbs produced in mice by conventional hybridoma 
methodology are specific for this protein. Therefore, characteristics and antigenic variation 
of the N protein have been extensively studied. The N protein does not induce neutralizing 
activity. 
Nelson et al. (1993) generated 3 MAbs (SDOW17, EP147 and V017) by immimizing 
mice with North American PRRS viruses ATCC VR-2332 and SDl. They tested the sero-
reactivity of these 3 MAbs with 63 North American PRRS viruses and 57 European viruses 
including ATCC VR-2332 and the Lelystad virus. Monoclonal antibody SDOW17 reacted 
with all North American and European viruses and MAbs EP147 and V017 reacted with all 
North American viruses but not with any of the European viruses. Magar et al. (1995) 
observed that these 3 MAbs reacted with all of 20 North American PRRS viruses including 
ATCC VR-2332 but again MAbs EP147 and V017 did not react with the Lelystad virus. 
Yoon et al. (1995a) reported that MAbs SDOW17 and EP147 reacted with 22 North 
American viruses but MAb EP147 did not react with 3 of these viruses. 
Drew et al. (1995) generated 5 MAbs (WBEl, 3 through 6) by immunizing mice with 
the European virus H2 and tested sero-reactivity of these MAb with 25 European and 8 North 
American PRRS viruses. Monoclonal antibodies WBEl, 4, 5 and 6 reacted with the Lelystad 
virus and all of the other 24 European viruses. Monoclonal antibody WBE3 reacted with 4 
of the European viruses but not with the Lelystad virus. None of these 5 MAbs reacted with 
any of the 8 North American viruses tested. Subsequently, Le Gall et al. (1997) observed 
that MAbs WBEl and 4 through 6 reacted with 13 European viruses but only MAb WBEl 
reacted with 3 North American viruses, indicating their difference in recognition of specific 
epitopes. 
Van Nieuwstadt et al. (1996) prepared MAbs 126.9 and 122.17 by immunizing mice 
with the Lelystad virus. Both MAbs reacted with the Lelystad virus and ATCC VR-2332. 
Monoclonal antibody 126.9 also reacted with all of 15 European viruses tested but not with 3 
North American viruses (Le Gall et al., 1997). Monoclonal antibody 122.17 was not tested 
against these viruses. 
Monoclonal antibody P3/27 raised against the Dutch virus 110 or 12 (not specified in 
literature) reacted with all of 27 European viruses including the Lelystad virus and 15 North 
American viruses (Le Gall et al., 1997; Wieczorek-Krohmer et al., 1996). Monoclonal 
antibody IAFK8 raised against the North American virus lAF-Klop reacted with 2 European 
viruses including the Lelystad virus and 15 North American viruses including ATCC VR-
2332 (Dea et al., 1996). 
Rodriguez et al. (1997) reported that 7 MAbs (1CH5, IDHIO, IBDl 1, 1EB9, 1DA4, 
I AGl 1 and 1AC7) raised against the European virus Olot/91 reacted with the homologous 
virus and only MAbs 1DA4, 1 AGl 1 and 1AC7 reacted with the North American virus 
Quebec 94. Le Gall et al. (1997) further reported that MAb 1CH5 reacted with an additional 
15 European viruses but not with 3 North American viruses. 
Among the MAbs described above, MAbs SDOW17, EP147, V017, 1CH5 and 
IDHlO did not react with denatured antigen in Westem immimoblotting, suggesting these 
MAbs may be specific for discontinuous epitopes (Nelson et al., 1993; Rodriguez et al., 
1997). All other MAbs reacted with denatured antigen in Westem immimoblotting, 
suggesting these MAbs may be specific for continuous epitopes. 
In siimmaiy, at least 3 distinct continuous epitopes are associated with the N protein 
and may be represented by MAbs WBEl, 3,4, 5 or 6. The epitopes represented by MAbs 
WBE3 and WBE 4, 5 or 6 are present in European viruses. The epitopes represented by 
MAbs WBEl and P3/27 are present in both European and North American viruses. In 
addition, at least 4 discontinuous epitopes are represented by MAbs SDOW17, V017, EP147 
and possibly 1CH5. Monoclonal antibody SDOW17 reacts with both North American and 
European viruses including the Lelystad virus, MAbs V017 and EP147 react with North 
American viruses only, and MAb 1CH5 apparently reacts only with European viruses. 
Rodriguez et al. (1997) used Western immunoblotting to characterized the N protein 
into 3 antigenic sites (I, n and m). They cloned and expressed 6 overl^ping segments of 
ORF 7 of the European virus Olot/91, designated A through F, in a baculovirus system. 
They subsequently tested the expressed products for reactivity with a panel of MAbs. 
Antigenic site I represented a discontinuous epitope that was recognized by MAbs 1CH5 and 
IDHIO. Antigenic site 11 represented a continuous epitope encoded by nucleotide segments 
A and B because the proteins expressed from these fragments was recognized by MAbs 
IBDl 1 and 1EB9. Antigenic site HI also represented a continuous epitope encoded by 
nucleotide segments E and F because the proteins expressed from these fragments were 
recognized by MAbs 1DA4, 1 AGl 1 and 1AC7. 
Nelson et al. (1997) reported that the substitution of the amino acid aspartic acid at 
position 61 by tyrosine caused failure of MAb SD0W17 to react with the modified-live 
vaccine PRIME PAC PRRS, suggesting the presence of an epitope around this area of the N 
protein. In addition, Wootton et al. (1998) generated a series of deletion mutants of the N 
protein and tested them for sero-reactivity with a panel of MAbs. Their results suggested that 
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the C-terminal of the N protein played an important role in the formation of discontinuous 
epitopes. 
The monoclonal antibodies described here and their characteristics are summarized in 
Table 4. The sero-reactivity of these MAbs with the Lelystad virus and ATCC VR-2332 is 
indicated. 
Table 4. Monoclonal antibodies specific for the N protein of PRRS viruses 
Reference MAb Epitope LV VR-2332 Other EUs Other NAs 
Nelson et al., 1993 SDOW17 D + + 56/56 62/62 
EP147, V017 D - + 0/56 62/62 
Magar et al., 1995 SDOW17, D - 19/19 
EP147, V017 
Yoonetal., 1995a SDOW17, V017 D nt nt 22/22 
EP147 D 19/22 
Drewetal., 1995 WBEl, 4, 5, 6 C + nt 24/24 0/8 
WBE3 C 
-
nt 4/24 0/8 
Le Gall et al., 1997 WBEl C 13/13 3/3 
WBE4, 5, 6 C 13/13 0/3 
Van Nieuwstadt et al.. 126.9, 122.17 C + 
1996 
Le GaU et al., 1997 126.9 C 15/15 0/3 
Wieczorek-Krohmer et P3/27 C + nt 16/16 12/12 
al., 1996 
Le Gall et al., 1997 P3/27 C 10/10 3/3 
Deaetal., 1996 L\FK8 C + + 1/1 15/15 
Rodriguez et al., 1997 1CH5, IDHIO D nt nt 1/1 0/1 
IBDll, 1EB9 C nt nt 1/1 0/1 
1DA4, lAGll, C nt nt 1/1 1/1 
1AC7 
Le GaU et al., 1997 1CH5 D 15/15 0/3 
D, discontmuoiis; C, continuous; nt, not tested; EUs, European viruses; NAs, North American viruses 
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M protein 
The M protein is a non-glycosylated, envelope-associated protein. Resiilts from 
genetic analysis suggest that the M protein of PRRS viruses of the same continent origin are 
the most conserved. However, a vast antigenic difference has been demonstrated between 
North American and European viruses. A total of 5 MAbs specific for the M ptotein have 
been generated. These MAbs represent 4 continuous epitopes as detennined by their sero-
reactivity patterns with PRRS viruses. The monoclonal antibodies 122.9 and 126.3 raised 
against the Lelystad virus (van Nieuwstadt et al., 1996) react with the Lelystad virus but only 
MAb 122.9 reacts with the North American virus ATCC VR-2332. The monoclonal 
antibodies 2C12 raised against North American virus LHVA-93-3 (Magar et al., 1997) and 
MAbs IAFK3 and 6 raised against the North American virus lAF-Klop (Dea et al., 1996) 
represent two separate epitopes that appear to be present only in North American viruses. 
Monoclonal antibody 2C12 reacted with ATCC VR-2332 but not with the Lelystad virus. 
Monoclonal antibodies IAF3 and 6 did not react with either ATCC VR-2332 or the Lelystad 
virus. No discontinuous epitopes of the M protein have been described. 
The monoclonal antibodies described here and their characteristics are summarized in 
Table 5. The sero-reactivity of these MAbs with the Lelystad virus and ATCC VR-2332 is 
indicated. 
GP2 protein 
The GP2 protein is a minor structural envelope associated glycoprotein of the 
Lelystad virus (Meulenberg and Petersen-Den Besten, 1996). It has not been demonstrated 
in any of the North American PRRS viruses to date. No MAb specific for this protein has 
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been produced to date. The function and antigenic variation of the GP2 protein of PRRS 
viruses have not been determined. 
Table 5. Monoclonal antibodies specific for the M protein of PRRS viruses 
Reference MAb Epitope LV VR-2332 Other EUs Other NAs 
Van Nieuwstadt et al., 1996 126.3 C •r 
122.9 C 
LeGaUetal., 1997 122.9 C 15/15 2/3 
Magaretal., 1997 2C12 C + 0/13 121/121 
Le GaU et al., 1997 2C12 C 0/15 2/3 
Dea et la., 1996 IAFK3 
IAFK6 
C 0/2 10/15 
C, continuous; EUs, European vinises; NAs, North American viruses 
GP3 protein 
The GP3 protein is envelope associated. It has been demonstrated in European 
viruses H2, Lelystad, 110 and 12 (Drew et al., 1995; van Nieuwstadt t al., 1996; Wieczorek-
Krohmer et al., 1996) and is described by these investigators to be a minor structural 
component of the virion. Its molecular weight ranges firom 45 to 50 kD (Van Nieuwstadt et 
al., 1996), or fi-om 40 to 50 kD (Wieczorek-Krohmer et al., 1996) as determined by SDS-
PAGE. A homologous protein has been demonstrated in the North American virus lAF-Klop 
(Gonin et al., 1998; Mardassi et al., 1998). These investigators believe that GPS is not a 
structural component of mature virions. Antisera and MAbs specific for this protein do not 
have neutralizing activity. All MAbs generated to date for GP3 represent continuous 
epitopes. 
At least 6 continuous epitopes have been associated with GP3 as determined by sero-
reactivity patterns of MAbs with North American and European PRRS viruses. Five of these 
epitopes are represented by MAbs P7/al-19, P9/a3-20, P9/b3-l, P7/a2-55 and P7/b2-14 that 
were prepared by Wieczorek-Krohmer et al. (1996) using the Dutch virus 110 or 12. These 5 
MAbs represent distinct sero-reactivity patterns with 17 European viruses including the 
Lelystad virus and 12 North American viruses. The virus ATCC VR-2332 was not included 
in their study. A sixth epitope was represented by MAb WBE2 that was raised against the 
European PRRS virus H2 (Drew et al., 1995). This MAb reacted with 16 of 25 European 
viruses and not with any of 8 North American viruses. Three epitopes represented by MAbs 
P7/al-19, P9/a3-20 and P9/b3-l were present in both European and North American viruses 
while 3 other epitopes represented by MAbs P7/a2-55, P7/b2-14 and WBE2 were only 
detected in European viruses. All 6 epitopes were represented in the Lelystad virus. 
A possible fourth epitope of GP3 common to European and North American viruses 
was represented by MAbl22.14 that was prepared by Van Nieuwstadt et al. (1996) using the 
Lelystad virus. This MAb reacted with the Lelystad virus but not with ATCC VR-2332. 
Further comparisons by Le Gall et al. (1997) using 15 European and 3 North American 
viruses showed that MAbs P9/a3-20, 122.14 and WBE2 were distinct with respect to their 
sero-reactivity patterns. 
Antigenic variation between European and North American viruses is ^parently 
mediated by differences located at the C-terminal portion of the GP3 protein (Katz et al., 
1995). Swine antisera raised against European viruses reacted in the IPMA test with a 199 
amino acids located at the hydrophilic C-terminal of GP3 of the Lelystad virus that was 
expressed as a recombinant fusion protein (BP03-P) in a baculovirus system, but swine 
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antisera raised against North American viruses did not. Rabbit antisera raised against BP03-
P did not neutralize European or North American viruses. 
The monoclonal antibodies described here and their characteristics are summarized in 
Table 6. The sero-reactivity of these MAbs with the Lelystad virus and ATCC VR-2332 is 
indicated. 
Table 6. Monoclonal antibodies specific for the GPS protein of PRRS viruses 
Reference MAb Epitope LV VR-2332 Other EUs Other NAs 
Wieczorek-Krohmer et al., 1996 P7/al-I9 C + nt 16/16 12/12 
P9/a3-20 C nt 12/16 12/12 
P9/b3-l C + nt 13/16 12/12 
P7/a2-55 C + nt 13/16 0/12 
P7/b2-14 C •T nt 12/16 0/12 
Le Gall et al., 1997 P9/a3-20 C 10/10 3/3 
Drew et al., 1995 WBE2 C nt 16/25 0/8 
Le Gall et al., 1997 WBE2 C 8/13 0/3 
Van Nieuwstadt et al., 1996 122.14 C -
Le Gall et al., 1997 122.14 C 14/15 3/3 
C, continuous; nt, not tested; EUs, European vinises; NAs, North American viiuses 
GP4 protein 
The GP4 protein is a minor structural protein of PRRS viruses. Its molecular weight 
ranges fi-om 31 to 35 kD (Van Nieuwstadt et al., 1996), or firom 30 to 40 kD (Wieczorek-
Krohmer et al., 1996) as determined by SDS-PAGE. 
The GP4 protein is represented by at least 3 and as many as S continuous epitopes as 
determined by sero-reactivity patterns and neutralizing activity of MAbs with specific 
European viruses (Le Gall et al., 1997; Meulenberg et al., 1997; van Nieuwstadt et al., 1996; 
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Weiland et al., 1999; Wieczorek-Krohmer et al., 1996). Three qjitope were represented by 
MAbs P3/35, P7/bl-7 and P7/bl-2 that were raised against the Dutch virus 110 or 12 
(Wieczorek-Krohmer et al., 1996; Weiland et al., 1999). Two of these epitopes are 
represented by neutralizing MAbs P3/35 and P7/bl-7. A third epitope is represented by the 
non-neutralizing MAb P7/bl-2. 
An antigenic region spanning amino acids 40-79 of GP4 of the Lelystad virus was 
identified by using a panel of 15 MAbs including MAbs 122.68 and 121.4 (Meulenberg et 
al., 1997). These MAbs were raised against the Lelystad virus. Although both MAbs 
recognized this region only MAb 122.68 had neutralizing activity, indicating that the 2 MAbs 
represent different epitopes. In a comparative study by Le Gall et al. (1997), MAb 122.68 
differed from the neutralizing MAb P3/35 with respect to sero-reactivity patterns with 1 
North American and 2 European PRRS viruses. Comparative data is not available to 
determine if MAb 122.68 represents the same or a different epitope as MAb P7/bl-7. 
Zhang et al. (1998) also described a group of 4 MAbs that were prepared by using the 
recombinant GP4 of the North American virus ATCC VR-2385 expressed in baculovirus 
system. These MAbs represented at least 1 discontinuous epitope present among 23 North 
American viruses as tested by using the ELISA. 
The monoclonal antibodies described here and their characteristics are simimarized in 
Table 7. The sero-reactivity of these MAbs with the Lelystad virus and ATCC VR-2332 is 
indicated. 
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Table 7. Monoclonal antibodies specific for the GP4 protein of PRRS viruses 
Reference MAb Epitope VN LV VR-2332 Other EUs Other NAs 
De Kluijver et al., 13 MAbs nd nt - 4/19 0/4 
1995 (122.68 etc.) 
Le GaU et al., 1997 122.68 4/16 1/3 
Van Nieuwstadt et al.. 122.1, C -t- -t- _ 1/2 
1996 122.29, 
126.1, 130.7 
Meulenberg et al.. 14 MAbs C -f + -
1997 (122.1, 
122.29, 
122.68, 
126.1, 
130.7, etc.) 
121.4 C 
- -
W ieczorek-Krohmer P3/35 C nt + nt 10/16 0/12 
etal., 1996 P7/a2-7 
P7^1-2 
P7/bl-7 C nt + nt 9/16 0/12 
Weiland et al. ,1999 9 (P3/35, C + 
P7/a2-7 etc.) 
P7/bl-2, C -
P7/bl-7 
Le Gall et al., 1997 P3/35 C nt nt 6/16 0/3 
Zhang et al., 1998 PP4bB3, D - nt nt 23/23 
PP4bC5. 
PP4cBll, 
PP4dG6 
nd, not deteimined; nt, not tested; C, continuous; D, discontinuous; EUs, European viruses; 
NAs, North American viruses 
GPS protein 
The GPS protein is a major envelope-associated glycoprotein and is a major target for 
neutralizing antibodies. Persch et al. (1995) demonstrated that GPS induced neutralizing 
antibodies to PRRS virus by inoculating pigs with GPS cut from PAGE gels. In addition, 
Pirzadeh and Dea (1998) reported that vaccination with a plasmid DNA containing ORF5 of 
PRRS virus lAF-Klop induced neutralizing antibodies in pigs. Neutralizing activity was not 
induced by GPS expressed by Escherichia coli (E. coli). Evidence of neutralizing activity 
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induced by GPS has been provided by Gonin et al. (1999). These investigators compared 
neutralizing antibody titers of convalescent sera from PRRS virus-infected pigs to ELISA 
antibody titei^ using E. co//-recombinant N, M, GPS, GP4 and GPS proteins as antigen. A 
highly significant correlation was observed between neutralizing titers and antibody specific 
for GPS but not with antibodies specific for the N, M, GPS or GP4. 
At least 4 continuous and 2 discontinuous epitopes of GPS have been identified by 
sero-reactivity patterns with specific MAbs. Pirzadeh and Dea (1997) prepared 5 MAbs by 
immunizing mice with an E. co//-expressed ORF S gene product representing North 
American virus lAF-Klop. These MAbs represented at least 2 epitopes based on their ability 
to neutralize viruses lAF-Klop and ATCC VR-2332. Monoclonal antibodies IAF8A8 and 
1B8 neutralized both viruses but MAbs 2A5, 3A12 and ICIO only neutralized lAF-Klop. 
Neither group of MAbs sero-reacted with the Lelystad virus. A third continuous epitope that 
does not induce neutralizing antibody was detected by Zhang et al. (1998) in North American 
viruses. Zhang et al. (1998) also described 2 discontinuous epitopes present among North 
American viruses one of which induced neutralizing antibody. 
A unique continuous epitope of the GPS protein represented by MAb P10/b38 was 
only detected in a clone of the Dutch virus 110 but not in any of 12 American viruses or S 
European viruses including the Lelystad virus (Weiland et al., 1999). This epitope also 
induced neutralizing antibody. 
The monoclonal antibodies described here and their characteristics are summarized in 
Table 7. The sero-reactivity of these MAbs with the Lelystad virus and ATCC VR-2SS2 is 
indicated. 
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Table 8. Monoclonal antibodies specific for the GPS protein of PRRS viruses 
Reference MAb Epitope VN LV VR-2332 Other EUs Other NAs 
Pirzadeh and Dea, 1997 IAF-8A8 C + - 1/1 
IAF-1B8 
IAF-2A5 C - - 1/1 
IAF-3A12 
lAF-lClO 
Zhang et al., 1998 PP5dH4 C + nt nt 23/23 
PP5dB4 D 
-
nt nt 23/23 
PP5eA12 D - nt nt 23/23 
PP5cH5 
PP5cG12 
Weiland et al., 1999 Pl/b4 C + - nt 1/6 0/12 
C, continuous; D, discontinuous; nt, not tested; EUs, European vinises; NAs, North American viruses 
Changes of epitopes during virus passage in pigs 
Although a number of studies have repeatedly demonstrated the presence of antigenic 
variation of field PRRS viruses, little is known about how soon epitopes of proteins change 
during virus persistence in pigs. Le Gall et al. (1997) passaged 2 viruses (I and II) in pigs 
and compared sero-reactivity of recovered and parent viruses with a panel of 14 MAbs 
specific for the N, M, GP3 and GP4 proteins. Virus I was maintained in pigs for 27 weeks. 
This period included 3 weeks in sows, 19 weeks in their offspring and 5 weeks in contact 
pigs. One virus recovered from a contact pig lost an epitope of the GP3 protein. Virus n 
was maintained in pigs for 5 weeks. One of the 5 recovered viruses gained the same epitope 
that was not present in virus II before passage. This epitope is present in GP3 of some 
European PRRS viruses tested and is represented by MAb WBE 2 (Drew et al., 1995). No 
other changes occurred in the epitope profiles of viruses I and n following passage in pigs. 
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Immune responses 
Humoral Immune Response 
The ontogeny of the humoral immune response to PRRS virus has been characterized 
by several investigators. Virus-specific IgM antibody was detected by the IFA test as early 
as one week post-infection (p.i.), reached maximum levels by 2 weeks p.i., and persisted for 
5 weeks (Loemba et al., 1996; Vezina et al., 1996). Virus-specific IgG was initially detected 
from one to 3 weeks p.i., reached maximimi levels by 3 to 6 weeks p.i., and persisted for over 
20 weeks (Albina et al., 1992; Cho et al., 1996; Frey et al., 1992; Loemba et al. 1996; 
Morrison et al., 1992; Nelson et al., 1994; Vezina et al., 1996; Wensvoort et al., 1991; Yoon 
et al., 1992b, 1994,1995b). Neutralizing antibody titers were initially detected 
approximately 1-2 months p.i. and remained for 9 months p.i. (Kwang et al., 1999; Nelson et 
al., 1994; Yoon et al., 1995b). When a modified SVN test using 20% fresh swine serum as a 
virus diluent was utiUzed, the neutralizing antibody was detected 9-11 days p.i. and reached 
maximum levels by 41-45 days p.i. (Yoon et al., 1994). 
The ontogeny of the antibody response to structural proteins N, M and GPS proteins 
of PRRS viruses is variable. Nelson et al. (1994) evaluated the humoral immune response of 
pigs infected with ATCC VR-2332 by Westem immunoblotting (WI). These investigators 
found that antibodies specific for the N protein were detected as early as 7 days p.i., and for 
the M and GP5 proteins as early as 15-21 days p.i. Yoon et al. (1995b) reported similar 
findings in pigs exposed to the North American vims ATCC VR-2402 (ISU-P). Antibodies 
specific for the N protein were detected by WI at 7 days p.i. Antibodies specific for the M 
and GPS proteins were detected by 9-28 days p.i. Bautista et al. (1994) reported that 
antibodies to the N, M and GPS proteins of ATCC VR-2332 were detected by 
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radioimmunoprecipitation at 28, 7, and 21 days p.i., respectively. Loemba et al. (1996) 
detected antibodies by WI to the N and M proteins in naturally and experimentally infected 
pigs by 14 days p.i., and antibodies to GPS by 7 days p.i. 
Cell-mediated immune response (CMI) 
Limited information is available on the development of cell-mediated immunity 
(CMI) in pigs to PRRS virus. Vezina et al. (1996) observed a significant enhancement of in 
vitro uptake of [^H]-thymidine in peripheral blood lymphocytes that were collected ftom 
PRRS virus infected pigs at 7 or 14 days p.i. Bautista et al. (1999) demonstrated T-cell 
proliferation in addition to delayed-type hypersensitivity (DTH) responses in pigs. 
Lymphocyte proliferation following expostire to whole virus antigen was first detected at 4 
weeks p.i., reached maximum values at 7 weeks and declined to imdetectable levels by 11 
weeks. Bautista et al. (1999) also compared the effectiveness of the N, M, GP2, GP4 and 
GPS proteins as antigens in the lymphocyte proliferation assay. These antigens were either 
produced in a vaccinia virus expression system or obtained from PAGE gels. The M protein 
was the most efficient antigen, suggesting that it played a major role in inducing CMI. The 
DTH reaction that was observed in pigs exposed to PRRS virus was directly proportional to 
the dose used as antigen. 
Both natural and experimental PRRS virus infection alters the T-cell subpopulations 
(CD4VCD8'^ in the peripheral blood of pigs. Shimizu et al. (1996) reported that the nimiber 
of CD4'^ Th cells decreased for at least 14 days p.i. while CDS* Tc cells increased and 
reached maximum levels at 28-3 S days p.i. In contrast, Zhou et al. (1992) reported that the 
CD4'^ subpopulation increased and the CDS"^ subpopulation decreased in infected pigs. 
Similar variable responses have been reported in studies measuring the effect of PRRS virus 
infection on the ftmction of alveolar macrophages and natural killer cells (Chiou et al., 1999; 
Lamontage et al., 1999; Lopez-Fuertes et al., 1999; Nielsen et al., 1999; Samsom et al., 1999; 
2000). Reasons for these variable responses include: variation in pathogenicity among PRRS 
viruses used in these experiments, difficulty in studying alveolar macrophages due to their 
heterogeneous populations, and the microbial status and susceptibility of experimental pigs 
(Zimmerman et al., 1998). These investigators were not able to show a conrelation between 
these affects and the ontogeny of the immune response or the pathogenesis of PRRS virus 
infection. 
The role of cytokines in regulating immime response to PRRS virus infection has not 
been extensively characterized to date. A major focus of studies to date has been on the role 
of interferon-y (IFN-y) (Meier et al., 1999). These investigators were not able to detect IFN-y 
producing cells in pigs until 8-10 weeks p.i. The number of these cells then increased 
gradually to maximum levels by 9-10 months p.i. and remained at these levels for 300 to 690 
days p.i. when the pigs were killed. These investigators also demonstrated in vitro that IL-12 
enhanced the IFN-y response and IL-10 suppressed the IFN-y response. It was assimied that 
IFN-y would play a role in controlling PRRS. However, no correlation was able to be 
demonstrated between the level and duration of IFN-y in the host and the ontogeny of the 
immune response and status of persistent virus infection. 
Persistent infectioii 
Although pigs produce neutralizing antibodies and cell-mediated immunity to PRRS 
virus infection, a nvimber of studies have shown that the virus can establish a persistent 
infection as determined by virus isolation and detection of viral genomic materials. 
Zimmerman et al. (1992) reported that the PRRS virus ISU-P spread from clinically healthy 
pigs to contact pigs 99 days after being infected. Albina et al. (1994) reported the spread of 
PRRS virus from 15-week-old pigs bom to infected sows to contact pigs. Christopher-
Hennings et al. (1995) reported the detection of viral RNA fix)m semen samples of 2 boars at 
92 days p.i. and the isolation of virus from the bulbourethral gland of a boar at 101 days p.i. 
Wills et al. (1997) recovered PRRS virus from oropharyngeal scrapings at 157 days p.i. 
Benfield et al. (1997) demonstrated that pigs bom to sows infected during gestation became 
infected and shed the virus for periods up to 112 days after birth. Viral RNA was also 
detected in these pigs up to 210 days of age. 
Lymph nodes and tonsils are sites of persistent PRRS virus infection (Benfield et al., 
1997; Horter et al., 2000; Wills et al., 1997). Osorio (1998) recovered the PRRS virus from 
tonsils of pigs up to 150 days p.i. (impublished data). Wills et al. (1999) detected viral RNA 
from tonsil biopsies of 4 pigs at 251 days p.i. The testes of boars are also a site that harbors 
the PRRS virus (Sur et al., 1997). The eye has also been suggested as a site of virus 
persistence (Shin and Molitor, 1998). 
The mechanisms for the establishment and maintenance of persistence of PRRS virus 
infection are not known. Antigenic variation and subsequent evasion of the immime system 
is a possible mechanism (Ahmed et al., 1996). 
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Prevention and control 
Prevention and control of PRRS have been a priority for the swine production 
industry since this disease emerged. Management protocols with and without vaccination 
programs have been used with variable success to control PRRS. 
Management protocols 
A variety of management protocols with and without concurrent use of vaccine have 
been used for prevention and control and for eradication of PRRS virus from herds. These 
methods include total depopulation, test and removal (Andreasen, 1999; Blanquefort and 
Benoit, 1999; Dee and Molitor, 1998; Dee et al., 1996a, 1996b, 1999; Plomgaard, 1998), 
medicated early weaning (MEW) and segregated early weaning (SEW) (Christianson et al., 
1994; Donadeu et al., 1999; Gramer et al., 1999; Rajic et al., 1999), and MCREBEL 
(Management Changes to Reduce Exposure to Bacteria to Elimination Losses) (McCaw, 
1995). 
Identification of clinically normal but persistently infected pigs is critical for the 
success of eradication protocols since PRRS virus infection does not always cause clinical 
problems. These apparently healthy pigs are the most important source of infection. 
Serological tests including the IF A, SVN and ELISA, separately or in combination with the 
RT-PCR are used to detect the presence of inapparently infected pigs in herds (Dee, 1999; 
Dee and Philips, 1999; Donadeu et al., 1999). 
Vaccination 
Two modified-live vaccines (RespPRRS/Pro and Prime Pac PRRS) and 1 inactivated 
vaccine (PromisePRRS) were developed by Boehringer Ingelheim/NOBL Laboratories, 
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Schering-Plough Animal Health and Bayer Corporation, respectively (Bayer Corporation, 
1999; Gorcyca et al., 1995; Hesse et al., 1996) and are currently available in the United 
States. Vaccine-induced immunity has been shown to prevent reproductive failure in 
endemic areas. However, their use and efTectiveness are controversial (Gillespie, 1995; 
Gorcyca et al., 1995; Joo et al., 1998b; Sanford and Nuhn, 1996; Somsen et al., 1998a; 
1998b; Trayer, 1995). 
Experimental studies have shown that vaccinated pigs can spread modified-live 
vaccine viruses to non-vaccinated pigs. Christopher-Hennings et al. (1997) vaccinated boars 
with the modified-live vaccine RespPRRS. At 39 days post-vaccination the semen samples 
remained positive by RT-PCR testing. Mengeling et al. (1999a) investigated the potential of 
the modified-live vaccine RespPRRS for virus shedding, persistence and mutation during 
replication in sows. They recovered the attenuated virus at 14 days post-vaccination. In 
another study using the vaccine RespPRRS, Mengeling et al. (1999b) recovered the vaccine 
virus at 37 days post-vaccination and observed a partial protection against subsequent 
challenge. The transmission of the modified-live vaccine virus RespPRRS fi-om vaccinated 
to non-vaccinated pigs has also been dociunented by other researchers (Dee et al., 1996a; 
Somsen et al., 1998b). Vaccination with RespPRRS/Repro in Danish herds caused severe 
outbreaks of PRRS in 1996 (Bertner et al., 1997). The viruses isolated fi-om affected pigs had 
identical nucleotide sequences to ATCC VR-2332, the progenitor of the vaccine virus 
(Madsen et al., 1998; Storgaard et al., 1999). These studies suggest that vaccination 
programs involving the modified-live vaccine virus should be implemented carefiilly in the 
field. 
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Osorio et al. (1998) compared 2 commercially available modified-live vaccines and 1 
inactivated autogenous vaccine for their ability to induce protection against an acute PRRS 
virus disease. Parameters of this study included the ELISA and SVN antibody titers, cell-
mediated immimity as measured by IFN-y producing cells in peripheral blood mononuclear 
cells, viremia and viability of piglets. No correlation was observed between protection and 
humoral and cell-mediated immunity. 
Modified-live vaccines are not recommended for immimization of gilts and sows 
during gestation. Attenuated virus can cross the placenta and infect fetuses (Mengeling et al., 
1996). 
Cross protection between and among European and North American viruses 
Both homologous and heterologous protective immimity against reproductive failure 
has been demonstrated among wild type North American field viruses (Lager et al., 1999a; 
1999b) and the vaccine virus RespPRRS (Hesse et al., 1996a; 1996b). However, 
heterologous protection was incomplete and persisted for a shorter period than homologous 
protection (Lager et al., 1999b). Similar conclusions were made by Labarque (1999) 
following cross protection studies using North American and European modified-live 
vaccines. 
Strain diflferentiation 
Both restriction firagment length polymorphisms (RFLPs) and epitope profiles have 
been used to differentiate vaccine viruses fix)m wild type PRRS viruses. The epitope profiles 
of PRRS viruses have also been used to differentiate North American viruses from European 
viruses (Nelson et al., 1993; Drew et al., 1995; Le Gall et al., 1997; Magar et al., 1995, 
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1997). For example, MAbs WBE4,5 and 6 specific for the N protein have been shown to 
react with all European PRRS viruses tested including the Lelystad virus (Drew et al. 1995; 
Le Gall et al., 1997). In contrast, MAb V017 specific for the N protein and MAb 2C12 
specific for the M protein have been show to react with all North American PRRS viruses 
tested including ATCC VR-2332 (Magar et al., 1995, 1997; Nelson et al., 1993; Yoon et al., 
1995a). Epitope profiles of PRRS viruses have also been used to monitor changes in PRRS 
virus populations in infected swine herds where killed autogenous vaccines are used (Nelson, 
unpublished data, 2000). 
Wesley et al. (1998) reported that the modified-live vaccine (RespPRRS/Repro, 
Boehringer Ingelheim/NOBL Laboratories, Sioux Center, Iowa, U.S.A.) and field viruses 
differ in the RFLP patterns of the RT-PCR products of ORF 5. Viral ORF 5 was amplified 
by using the non-nested-set RT-PCR. The RT-PCR products were cut by 3 restriction 
enzymes {Mlul, HincYL and SacU) and numerical codes were assigned to represent specific 
restriction patterns. The vaccine virus and ATCC VR-2332 exhibited identical RFLP 
patterns (2-5-2) which were different from the restriction patterns of 22 wild type viruses. 
The 22 wild type viruses were represented by 10 different patterns. Additionally, 50 PRRS 
viruses from 3 states (45 from Iowa, 4 from Illinois, and 1 from Minnesota) were tested using 
this method. The restriction patterns of the vaccine virus and ATCC VR-2332 were different 
from the patterns of all of these 50 viruses. 
Furthermore, Wesley et al. (1999) demonstrated that the RFLP patterns of 2 field 
viruses (2-5-2 SD and NADC-8) and a modified-live vaccine virus (RespPRRS/Repro) were 
stable during passage in pigs. Viruses were recovered from infected pigs 2-7 weeks p.i., 
from sentinel pigs at 3 weeks after contact with pigs that were inoculated 8 weeks previously. 
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and from 5-week-old piglets bom of sows that were inoculated with PRRS viruses 8 weeks 
before farrowing. The RFLP patterns and sequences of ORF 5 of parent and recovered 
viruses were compared. Some nucleotide substitutions were identified. These substitutions 
included 1 nucleotide in viruses recovered at 2 weeks p.i., 2 to 4 nucleotides in viruses 
recovered at 7 weeks p.i. and 5 nucleotides in viruses recovered fi^om 5 week-old piglets bom 
of infected sows. However, these substitutions did not cause changes in the RFLP patterns of 
any of the viruses recovered after passage. 
Umthum and Mengeling (1999) developed a nested-set RT-PCR for ORF 5 as an 
adjunct to the RFLP analysis described above. This type of PCR was 100 to 1000-fold more 
sensitive than the non-nested-set RT-PCR and could detect 1 infective imit of PRRS virus/ml 
in samples that included pulmonary lavage, serum and virus-infected MARC-145 cell 
lysates. 
Gagnon and Dea (1998) foimd that the RFLP patterns of RT-PCR fragments 
containing both ORFs 6 and 7 could also be used to differentiate North American viruses 
from the modified-live vaccine virus (RespPRRS/Repro). The RT-PCR products were cut by 
endonucleases Mspl, BsaJI, Alul and Haein. Fourteen out of 16 field viruses had RFLP 
patterns that were different from this modified-live vaccine virus. 
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ANTIGENIC AND GENETIC VARIATIONS OF THE 15 kD NUCLEOCAPSID 
PROTEIN OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS ISOLATES 
A paper published in the Archives of Virology' 
L. Yang^-^K.-J. Yoon^-^, Y. J.-H. Lee^ ^  J. J. Zimmerman^-^, 
M. L. Frey^K. M. Hannon^-^ and K. B. Platt^"-® 
Summary. The antigenic variability of the 15 kD nucleocapsid protein of porcine 
reproductive and respiratory syndrome (PRRS) virus was characterized with a panel of 24 
monoclonal antibodies (MAbs) raised against the American PRRS virus isolate ISU-P. Five 
continuous epitopes designated EpORF7-A through E were revealed by the reactivity pattern 
of these MAbs with 67 American field isolates, two modified-live vaccine viruses, and the 
European Lelystad virus as determined by the indirect immunofluorescence assay and 
Western immimoblotting and confirmed by additivity and blocking enzyme-linked 
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immunosorbent assays. The reactivity pattern of isolates in the IFA permitted their 
subdivision into 4 American antigenic groups which represented 84.1, 11.6,2.9 and 1.4% of 
viruses tested. The antigenic variation among isolates was correlated to single, group 
specific nucleotide substitutions and mediated by a combination of at least 4 of the 5 
epitopes. EpORF7-A was conserved in all American isolates and the Lelystad virus which 
constituted a separate antigenic group. Consequently, monoclonal antibodies specific for 
EpORF7-A may prove useful as the antigenic basis for a universal diagnostic test for the 
PRRS virus. EpORF7-C, D and E were only present in the American isolates tested. 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is a major disease of swine 
throughout the world. Clinical manifestations are characterized by reproductive failm-e in 
sows and gilts, pneumonia in grower/finisher pigs, and increased morbidity and mortality in 
preweaning pigs [11]. The syndrome was first reported as devastating outbreaks of 
reproductive failure in North Carolina, Minnesota, and Iowa in the United States during 1987 
and 1988 [12, 14]. In the years following, PRRS spread throughout the United States and 
Canada [12]. In 1990, the disease was recognized in Germany and soon afterwards in other 
Western European coimtries [35]. Presently, PRRS is endemic in most swine producing 
countries throughout the world. 
The etiologic agent responsible for the syndrome was first isolated by researchers in 
the Netherlands and identified as the Lelystad virus [33]. Soon after, a virus (ATCC VR-
2332) was isolated in the United States using the proprietary cell line CL2621 and identified 
as the swine infertility and respiratory syndrome (SIRS) virus [1,5]. Currently, the 
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International Office of Epizootics (O.I.E.) recognizes the teims Sindrome Disgenesico y 
Respiratorio del Cerdo (Spanish), Syndrome Dysgen^ique et Respiratoire du Pore (French), 
and Porcine Reproductive and Respiratory Syndrome (EngUsh). 
The PRRS virus is an enveloped RNA virus that is currently classified as a member 
of the family Arteriviridae [6, 22, 28]. The genome is a positive sense, 15 kb single strand of 
RNA consisting of 8 open reading frames (ORFs) which are expressed as a nested set of 
subgenomic RNAs. To date, 6 structural proteins with molecular masses of 15, 19, 25, 30, 
31, and 45 kD and their corresponding genes have been reported for the European Lelystad 
PRRS vims isolate [23,24, 31]. However, only 3 proteins with molecular masses of 15, 19, 
and 25 kD have been consistently detected in purified virions and lysates of cells infected 
with North American virus isolates [26,27]. 
Previous studies have shown that field isolates of PRRS virus vary antigenically. 
Antigenic variation among PRRS virus isolates was first demonstrated between North 
American and European PRRS virus isolates by the immunoperoxidase monolayer assay 
using PRRS virus-specific polyclonal antibodies [34]. Similar antigenic variation between 
the European and North American isolates was also shown by the indirect fluorescent 
antibody test using monoclonal antibodies (MAbs) specific for the 15 kD nucleocapsid 
protein [8, 16, 19, 26]. The MAbs responsible for these distinctions represented at least one 
epitope that was unique to American isolates, one epitope imique to European isolates and at 
least 3 epitopes present in both American and European isolates. Genomic diversity of ORF 
7 of European and American isolates has also been demonstrated by nucleotide sequence 
analysis [17, 21, 25, 30]. In the following study we describe the generation of a panel of 
MAbs to further characterize the antigenic nature of the 15 kD nucleocapsid protein and to 
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determine if a sufficient degree of antigenic variation exists in the 15 kD protein among field 
isolates that can provide the basis of a reliable virus marker system for use in 
epidemiological studies and for monitoring virus traffic in swine populations. 
Materials and methods 
Viruses, cells, and media 
A total of 70 PRRS viruses were used in the present study. These viruses included 
isolate ISU-P, ATCC VR-2332,2 modified-live vaccine viruses, PRIME PAC® PRRS 
(Schering-Plough Animal Health Corporation, Omaha, NE, USA) and RespPRRS/ReproTM 
(NOBL Laboratories, Sioux Center, lA, USA), the Lelystad virus [33] and 65 field isolates 
that were isolated between 1989 and 1995 from Canada, Guatemala, and 13 states of the 
United States of America (Table 1). All PRRS virus isolates were propagated and passaged 
Table 1. The geographic origins of PRRS virus isolates and modified-live vaccine viruses 
tested and their antigenic groups as determined by sero-reactivity with a panel of 
24 monoclonal antibodies in the indirect immunofluorescence antibody test 
Antigenic group 
Geographic origin I n m IV V 
Southeastern U.S. 29 2 I 
Midwestern U.S. IT 5 2 
Southwestem U.S. 1 
Canada 1 
Guatemala 1 
The Netherlands 1" 
Total 58 8 2 1 1 
® Includes PRRS viruses ISU-P, VR-2332 and the 2 modified-live vaccine viruses, PRIME PAC 
PRRS (Schering-Plough Animal Health Corporation, Omaha, NE, USA) and RespPRRS/Repro 
(NOBL Laboratories, Sioux Center, lA, USA) 
'' The Lelystad virus 
at least one time after initial isolation in MARC-145 cells, a clone of an Afiican green 
monkey kidney cell line [15]. The cells were grown and maintained in Dulbecco's modified 
Eagle's medium (DMEM) which was supplemented with 10% fetal bovine serum (FBS). 
Antigen preparation for MAb production 
Antigen for moase inunanization 
Semi-purified whole virus preparations sufficient to immunize 16 mice were prepared 
from eleven 75cm2 cell culture flasks of MARC-145 cell monolayers which were inoculated 
with PRRS virus isolate ISU-P at a multiplicity of infection of approximately 5. Inoculated 
cells were incubated at 37°C in a humid atmosphere containing approximately 5% C02. 
Four days later virus was harvested by 3 cycles of freezing/thawing at -80°C/+37®C followed 
by clarification at 2,000 x g for 30 mins at 4°C. The supernatant was subsequently 
centrifuged at 90,000 x g in a Ti 60 rotor (Beckman Instruments, Inc., Palo Alto, CA, USA) 
for 2 hrs at 4°C. The resulting pellet was resuspended in sqiproximately 1 ml of 0.01 M 
phosphate buffered saline (PBS), pH 7.4, overlaid onto a discontinuous sucrose gradient 
(30% and 60%), and centrifuged at 120,000 x g in a SW 28 rotor (Beckman Instruments, 
Inc., Palo Alto, CA, USA) for 70 mins at 4°C. The band at the interface of the 2 sucrose 
layers was collected. Two thirds of this material, which contained virus particles, was 
diluted in PBS to a total volume of 4 ml and emulsified in an equal volume of Freund's 
incomplete adjuvant (GIBCO Laboratories, Grand Island, NY, USA). This preparation was 
stored at 4°C until used. The remaining material was diluted to 4 ml in PBS and stored at -
70°C until used. 
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Antigen for Western immnnoblotting and the enzyme-linked immunosorbent 
assay (ELISA) 
MARC-145 cells were infected with PRRS virus ISU-P as described. Cells were 
harvested 4 days later, washed 2 times in PBS and pelleted by centrifiigation at 500 x g for 
15 mins at 4°C. Ten volumes of 0.25 M Tris/0.11 M tricine buffer, pH 8.6, containing 0.14 
mM calcium lactate and 1% (VAO Triton X-100 were added to one volume of packed cells, 
gently agitated overnight at 4°C and subsequently centrifuged at 2,000 x g for 20 mins at 4°C 
The supernatant containing solubilized antigen was harvested and stored at -20°C until used. 
MAb production 
Monoclonal antibody secreting hybridomas were generated from 6 to 8 week-old 
specific pathogen free BALB/c mice. Each mouse was given two 0.25 ml injections of 
antigen with adjuvant subcutaneously 2 weeks apart. Two to 3 weeks later, mice were given 
a third 0.25 ml injection of antigen without adjuvant. Three days later, mouse spleens were 
removed. Fusions of mouse spleen cells with mouse SP2/0 myeloma cells were carried out 
using the protocol described by Zola [38]. Hybridomas were screened for PRRS virus 
specific antibody secretion by the indirect ELISA. An indirect immunofluorescence assay 
(IFA) using normal and PRRS virus ISU-P infected MARC-145 cell monolayers as antigen 
[10] was used to confirm the identity of MAb secreting hybridomas. Antibody positive 
hybridoma populations were cloned 3 times with the EPIC 752 cell sorter (Coulter 
Corporation, Hialeah, PL, USA). Positive clones were identified by the IF A. The subclass 
and light chain type of individual MAbs were determined with a commercial mouse MAb 
isotyping kit (Boehringer Mannheim Corporation, Indiansqjolis, IN, USA). 
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Ascitic fluid containing specific MAbs was produced in 10 week-old BALB/c mice. 
All mice were primed with 0.5 ml pristane (2,6,10,14-tetramethyl-pentadecane) (Sigma 
Chemical Company, St. Louis, MO, USA) given intraperitoneally 10 days before inoculation 
with specific hybridomas. Each mouse was injected with approximately 107 hybridoma cells 
in 0.5 ml PBS by the intraperitoneal route. Ascitic fluid was harvested fiom anesthetized 
mice between 7 and 10 days post inociilation. Monoclonal antibodies were extracted fix>m 
ascitic fluid by protein A affinity chromatography using the protocol described by the 
manufacturer (Bio-Rad Laboratories, Hercules, CA, USA) and stored at -20°C. 
Indirect enzyme-linked immunosorbent assay (ELISA) 
Viral antigen and MARC-145 cell control antigen preparations were diluted to 
optimum concentrations in antigen coating buffer consisting of 0.02 M Na2C03/NaHC03, 
pH 9.6. One hundred ml of each preparation was added to individual wells in alternate rows 
of 96-well polystyrene microtiter plates (Immunlon I, Dynatech Laboratories, Inc., Chantily, 
VA, USA) and incubated first at room temperature for 1 hr and subsequently overnight at 
4°C. Excess viral and control antigen were removed and nonspecific binding sites in each 
well were blocked by adding PBS containing 10% FBS and incubating overnight at 4°C. The 
blocking solution was removed and the plates were stored in airtight plastic bags at -20°C 
until used. 
Supematants from hybridoma cultures were tested for antibody without dilution. 
Ascitic fluid was tested for antibody by first diluting it 1:100 in PBS containing 10% FBS. 
One hundred fil samples were added in duplicate to viral and cell antigen coated wells, 
incubated for 1 hr at 37°C and washed 4 times with washing buffer (PBS with 0.05% Tween 
20). Subsequently lOG nl of goat anti-mouse IgA+IgG+IgM (H+L) labeled with horseradish 
peroxidase (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA) was added to 
each well and incubated for 1 hr at 37°C. The plates were washed 4 times and 100 (il ABTS 
peroxidase substrate (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA) was 
added to each well. Reactions were allowed to develop for 20 mins at room temperature. 
The optical density (OD) of each well was determined at 405 nm using a computerized Vmax 
microtiter plate reader (Molecular Devices Corporation, Palo Alto, CA, USA). A signal to 
noise ratio of 1.5 was considered positive in the screening test. Serological reactivity in the 
additivity and blocking ELISA was expressed as a corrected OD which was calculated by 
subtracting the mean OD generated from cell control antigen from the mean OD generated 
from viral antigen. 
Additivity ELISA 
The additivity ELISA was conducted using a modification of the methods originally 
described by Friguet et al. [9] and Levieux et al. [18]. In brief, MAbs representing each 
MAb group (Table 2) were diluted to concentrations that would consistently react with all 
available epitopes in antigen coated wells. Fifty ^l of such an optimally diluted MAb was 
added to viral and cell antigen coated wells and incubated for 30 mins at 37°C. Subsequently 
50 ^l of the homologous MAb or heterologous MAb were added to the same wells and 
reacted for an additional hour at 37°C. Each reaction was conducted in duplicate. 
Antigen/antibody reactivity was visualized with horseradish peroxidase conjugate. Corrected 
CDs were determined at 405 nm for at least 3 replicates. Mean additivity values were 
calculated using the formula: 
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Table 2. Characterization of PRRS virus isolates and monoclonal antibodies specific for the 
15 kD nucleocapsid protein as detennined by their sero-reactivity in the indirect 
immunofluorescence antibody test 
PRRS virus Monoclonal antibody group 
No. of A B C D E 
Group isolates (n=7) (n=3) (n=3) (n=l) (n=10) 
I 
00 
+ + + + + 
n 8 + - + + + 
m 2 -f- + - + + 
IV 1 + + - + 
V 1" + +<= 
^ Includes PRRS viruses ISU-P, VR-2332 and the 2 modificd-live vaccine viruses, PRIME 
PAC PRRS (Schering-Plough Animal Health Corporation, Omaha, NE, USA) and 
RespPRRS/Repro (NOBL Laboratories, Sioux Center, lA, USA) 
^ The Leiystad virus 
Weak positive reaction 
Corrected OD MAb a + b 
AV = X 100 % 
(Corrected OD MAb a) + (Corrected OD MAb b) 
where MAbs "a" and "b" are any 2 MAbs tested for additivity. 
The additivity value (AV) of a homologous MAb combination should not be 
significantly greater than 50% whereas the AV resulting from a combination of 2 MAbs 
representing different and widely separated epitopes should approach 100%. Differences 
between homologous and heterologous MAb combinations were analyzed by Student's f-test. 
Blocking ELISA 
The blocking ELISA was perfonned essentially as described by Cecilia et al. [3]. In 
brief, affinity purified IgG preparations representing each of the 5 MAb groups summarized 
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in Table 2 were labeled with biotin hydrazide according to the manufacturer's instructions 
(Pierce, Rockford, IL, USA) and diluted to a concentration that would consistently react with 
all available epitopes in antigen coated wells. Purified unlabeled MAbs representing each 
MAb group were serially diluted 10-fold in PBS containing 10% FBS and used for blocking. 
Viral and cell antigen preparations were treated in duplicate with either blocking MAb or 
diluent and subsequently reacted with homologous or heterologous biotinylated MAbs. 
Antigen/antibody reactivity was visualized with peroxidase-labeled streptavidin (Kirkegaard 
& Peny Laboratories, Inc., Gaithersburg, MD, USA). Percent binding was calculated for 
each MAb interaction by comparing the corrected ODs generated in viral and cell antigen 
preparations treated with blocking MAb to the corrected ODs generated in antigen 
preparations that were treated with only diluent. The mean percent binding representing at 
least 3 replicates was calculated and plotted against dilution using the linear regression 
model. The one-way analysis of variance was used to test for differences at each dilution 
between homologous and heterologous interactions and among heterologous interactions 
mediated by individual blocking MAbs. Significant inhibition of binding by blocking 
antibodies was considered to be an indication of identity or interference by adjacent or 
overlapping epitopes. 
Western immunoblotting 
Western immimoblotting was done as previously described by Yoon et al. [37] with 
the exception that antigen preparations were mixed 1:1 with sample buffer containing 5% 
2-mercaptoethanol. 
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Virus neutralization test 
The microtiter serum virus neutralization test was used to assess the susceptibility of 
PRRS virus isolate ISU-P, the Lelystad virus and 4 individual American isolates representing 
virus antigenic groups I through IV to neutralization by MAbs representing groups A through 
E. Viruses were diluted in DMEM containing 10% FBS to yield approximate 200 TCID50 in 
50 |il. Ascitic fluid representing each MAb group was serially diluted two-fold in DMEM 
containing 10% FBS. Fifty |il aliquots of virus and MAb were added together in duplicate 
wells and incubated at 37oC for 1 hr. Subsequently 100 ^il containing approximately 10^ 
MARC-145 cells were added to virus/MAb mixtures and incubated for 7 days and observed 
for cytopathic effect. 
RT-PCR 
Viral RNA was extracted from 16 group I, 8 group U, 2 group HI and 1 group IV 
viruses using the protocol described by Boom et al. [2]. Individual viral RNA preparations 
were retrotranscribed using the protocol of the GeneAmp RNA PCR kit (Perkin Elmer, 
Roche Molecular Systems Inc., Branchburg, NJ, USA). Amplification of cDNA 
representing ORF 7 was mediated with the 2 oligonucleotide primers 5'-
TAAATATGCCAAATAACAAC-3' and 5'-TAGGTGACTTAGAGGCACA-3'. These 
primers were originally designed by Mardassi et al. [20] and synthesized for use in this study 
by the Iowa State University Nucleic Acid Facility. The amplification was performed for 40 
cycles by denatiuation at 94°C for 1 min, annealing at 56°C for 1 min, and extending at 72°C 
for 1 min. The time of the final extension step was 8 mins. The PCR products were purified 
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using a PCR DNA purification kit (Promega Corporation, Madison, WI, USA) by using the 
instructions of the manufacturer. 
Sequencing and sequence analysis 
DNA sequencing was performed in triplicate on both strands with the Applied 
Biosystems 377 automated sequencer (Applied Biosystems, Foster City, CA, USA) using 
Taq polymerase, fluorescein labeled dNTPs and the 2 primers previously described. 
Sequence analysis was conducted using programs of the GCG package developed by 
Genetics Computer Group, Inc. of Madison, Wisconsin. Nucleotide sequences were 
compared using the BESTFIT program and translated to amino acid sequences by the 
TRANSLATE program. Multiple alignment of the sequences was done with the PILEUP 
program. 
Prediction of the nucieocapsid protein structure 
Unique structiiral features and characteristics of the nucieocapsid protein of all PRRS 
viruses representing antigenic groups I through V that were sequenced were predicted from 
the translated amino acid sequences using the PEPTIDESTRUCTURE program of the GCG 
package. Parameters that were used to compare amino acid sequences included 
hydrophilicity, surface probability, flexibility, Jameson-Wolf (JW) antigenic indices [13], 
Chou-Fasman (CF) turns [5], CF alpha helices, CF beta sheets, Gamier-Osguthorpe-Robson 
(GOR) turns, GOR alpha helices, and GOR beta sheets. 
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Results 
Generation and characterization of MAbs 
Twenty-four MAbs were generated. All were of the IgGl subclass and possessed 
kappa light chains. These MAbs were specific for the 15 kD nucleocapsid protein of PRRS 
virus as determined by Western immunoblotting. All MAbs reacted with PRRS virus isolate 
ISU-P in the IFA and produced bright cytoplasmic fluorescence. None of the MAbs 
representing each group neutralized PRRS virus isolate ISU-P, the Lelystad virus or the 4 
other American isolates representing antigenic groups I through IV. 
Reactivity of MAbs with PRRS virus isolates 
Five distinct groups of MAbs (A-E) and four distinct groups of American isolates (I-
IV) and the Lelystad virus (group V) were revealed by sero-reactivity as determined by 
Westem immunoblotting and the IFA (Table 2). Monoclonal antibodies in group A were 
denominated as A1 through A7, group B as B1 through B3, group C as CI through C3, group 
D as DI, and group £ as £1 through £10. Virus group I represented 84.1% (58/69) of all 
American isolates tested including the 2 vaccine viruses and isolate ISU-P. Each isolate in 
this group reacted with all 5 groups of MAbs. Virus groups II, HI, and IV represented 11.6% 
(8/69), 2.9% (2/69) and 1.4% (1/69) of the American isolates respectively. Each of these 
virus groups was characterized by their reactivity with at least 4 of the 5 groups of MAbs. 
The Lelystad virus (group V) was only recognized by MAb groups A and B. Group A MAbs 
reacted strongly with Lelystad virus in the IFA as indicated by bright fluorescence. In 
contrast, group B MAbs reacted weakly with this virus in the IFA and not at all when 
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evaluated by Western inununoblotting, possibly due to partial identity. The geogr^hic 
origins of the PRRS viruses and their antigenic groups are summarized in Table 1. 
Epitopic analysis of the 15 kD nucleocapsid protein 
Results of additivity assays are summarized in Table 3. Additivity values for any 2 
MAbs tested that equal or ^proach 50% indicate identity as revealed by the calculated mean 
additivity value for all homologous reactions of 51.5 ± 0.4%. Conversely, additivity values 
for any 2 MAbs tested that differ significantly from 50% and ^proach 100% are indications 
that the 2 MAbs tested represent different epitopes. The mean additivity values for all 
Table 3. Epitopic analysis of the 15 kD nucleoc£^sid protein of PRRS virus isolate ISU-P 
by the additivity test using group representative MAbs Al, Bl, CI, D1 and El 
Test MAb 
Added MAb A B C D E 
None 0.97* 0.65 1.34 0.89 0.71 
A 50.5% 
(0.98/1.94)" 
B 78.4% 
(1.27/1.62) 
51.3% 
(0.67/1.30) 
C 82.7% 
(1.91/2.31) 
85.4% 
(1.70/1.99) 
53.0% 
(1.42/2.68) 
D 84.4% 82.5% 84.3% 51.1% 
(1.57/1.86) (1.27/1.54) (1.88/2.23) (0.91/1.78) 
E 75.6% 71.3% 86.3% 82.5% 51.4% 
(1.27/1.68) (0.97/1.36) (1.77/2.05) (1.32/1.60) (0.73/1.42) 
^ Optical density was measured at 405 nm. 
^ Additivity values expressed as binding percent were calculated using the formula; 
Corrected OD MAb a + 6 
AV = X 100 % 
(Corrected OD MAb a) + (Corrected OD MAb b) 
where MAbs "a" and "6" are any 2 MAbs tested for additivity. 
The measured OD values and theoretical sum of OD values of any 2 MAbs are indicated in 
parenthesis. The mean additivity values for any 2 heterologous MAbs are significantly increased 
(P < 0.001), as determined by Student's /-test. 
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heterologous comparisons was 81.3 ± 4.8% and ranged from 71.3% to 86.3%. These values 
were significantly different (p<0.001) from homologous additivity values indicating that 
MAbs representing groups A through E represent 5 different continuous epitopes hereafter 
referred to as EpORF7-A through E. 
Results of blocking assays that are siimmarized in Table 4 and Figure 1 also support 
the existence of at least 5 epitopes on the 15 kD protein. The mean percent binding for all 
homologous interactions at the lowest MAb dilution was 32.6 ± 2.7 and ranged from 28.0 ± 
2.3 to 34.3 ±1.1. All homologous interactions were significantly different from heterologous 
interactions (p < 0.001). No significant differences were detected among heterologous 
interactions when MAb representing EpORF7-A, B, C and D were used for blocking with the 
exception that the MAbs representing EpORF7-B and C interfered (p<0.05) with subsequent 
reactivity by the MAb representing EpORF7-E. Similar interference of reactivity of MAbs 
representing EpORF7-B, C and D was observed when MAb representing EpORF7-E was 
Table 4. Epitopic analysis of the 15 kD nucleocapsid protein of PRRS virus isolate ISU-P 
by the blocking ELISA using group representative MAbs Al, Bl, CI, D1 and El 
Blocking MAb 
Biotinylated MAb A B C D E 
A  + » . . . .  
B -b + . . +c 
C . . + . + 
D - . . + + 
E - ± ± - + 
' Significant (p < 0.001) inhibition 
""No inhibition 
Partial inhibition as indicated by significant blocking ( p < O.OS) at a magnitude of 1.8 - 2.0 less 
than that which was observed in homologous interactions. 
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Figure I, Competitive binding curves of 5 representative biotinylated MAbs A (0), B (V), C (T), D (•), and E (•) in the 
presence of blocking MAbs A through E 
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used for blocking (p<0.05). In both instances the magnitude of interference as demonstrated 
by percent binding among heterologous interactions was less than that observed among 
homologous interactions and ranged from 58.5 ± 2.4 to 64.2 ±1.8. These observations 
suggest that EpORFT- A, B, C, and D are spatially separate from each other while EpORF?-
E overlaps with or is adjacent to EpORF7- B, C and D. The postulated spatial relationship of 
these epitopes is presented in Figure 2. 
Figure 2. The spatial relationship of 5 continuous epitopes (EpORF7-A 
through E) of the 15 kD nucleocapsid protein of PRRS virus isolate 
ISU-P. Group representative MAbs Al, Bl, CI, Dl, and El were 
used. Circles that touch indicate that the epitopes are adjacent or 
overlap 
Comparison of ORF 7 of representative viruses of the 5 antigenic groups 
The nucleotide sequences of ORF 7 of 15, 8,2, and 1 representative viruses of 
antigenic groups I, n, HI, and IV respectively have been deposited in the GenBank with the 
accession numbers AF043949-AF043974. The nucleotide sequence of ORF 7 of 
RespPRRS/ReproTM vaccine virus (NOBL Laboratories) has been deposited in the GenBank 
with the accession number AF054970. These nucleotide sequences are presented in Figure 3. 
The deduced amino acid sequences of these viruses are summarized in Figure 4. The 
nucleotide and deduced amino acid sequences of ORF 7 of Lelystad virus and ATCC VR-
2332 [22,25] are presented for the purpose of comparison. The ORF 7 of all American 
PRRS virus isolates analyzed consisted of 372 nucleotides which encode 123 amino acids. 
In contrast, ORF 7 of Lelystad virus was 387 nucleotides long and hence 128 amino acids. 
Furthermore, 2 nucleotide segments corresponding to positions 38-51 and 372-387 in ORF 7 
of the Lelystad virus were not present in American viruses. Similarly, 2 nucleotide segments 
corresponding to positions 117-127 and 357-361 in ORF 7 of American viruses were not 
present in the Lelystad virus. 
Analysis of ORF 7 of the American isolates by the GCG package program revealed 
single, group specific nucleotide substitutions relative to virus group I that could account for 
unique antigenic differences. These nucleotide substitutions occurred at positions 358, 364 
and 209 in virus groups U, HI, and IV, respectively, and are indicated in Figure 4. In groups 
n and EH, thymidine at positions 120 and 122 respectively was replaced by cytidine which 
changed the encoded amino acid from serine to proline. In group IV, guanine at position 70 
was by adenine which changed the encoded amino acid from serine to asparagine. 
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Figure 3. Comparison of the nucleotide sequences of ORF 7 of representative PRRS viruses of antigenic groups I-V. The IS 
nucleotides at the S' end of ORF 7 are primer-derived. Dots represent bases identical to the consensus sequence, dashes 
indicate gaps introduced into the sequences, and the bold nucleotides are group-specific substitutions. The Lelystad 
virus and VR-2332 sequences used in this alignment were obtained from the GenBank [22, 25]. *The modified-live 
vaccine virus RespPRRS/Repro, manufactured by NOBL Laboratories, Sioux Center, lA, USA. ""The modified-live 
vaccine virus PRIME PACPRRS, manufactured by Schering-Plough Animal Health Corporation, Omaha, NE, USA. 
"A Canadian PRRS virus isolate. 
CONSENSUS TCGCCCAGCAAAACCAGTCCAGAGGCAAGQGACCGGGAAAGAAAAATAAGAAGAAAAACCCGGAGAAGCCCCATTTTCCTCI'AGCGACTQAAGATGATRT 
Group I VR-2332 T 
NOBL® T 
S-pb T C G T C.. 
ISU-P C 
09-46448 
91-46907 G.G T C 
92-01205 G T C 
92-11024 T 
93-6351 C C.. 
93-14620 T C..C T G..C..C.. 
93-22330 C.. 
93-27687 
93-44927 G T C 
94-10310 G C.. 
95-13536 T 
95-15299 T 
95-33010 T G C C. . 
Group II 89-46489 T G 
89-47361 T G 
89-47363 T G 
92-19698 C.. 
92-22332 T C..G C T C C.. 
93-22326 T G , C C. . 
93-47324C G G ! 
94-36093 T G T C 
Group III 92-6725 T C 
IA-D21 T G C C C. . 
Group IV 28523 G C. . 
Group V Lelystad .AAAGTCC. .GCG C.ACCTAGGGG.GGAC.GGGG, .0 G. .T A C. .G. .TG CA. 
Figure 3. (Continued) 
CONSENSUS CAGACATCACTTCACCCCTAGTGAQCGGCAArr 
Group I VR-2332 T C G C 
NODL® T C G C 
S - p b  C  T  A  T  C  C  
ISU-P T C C G 
89-46448 T G C 
91-46907 C 
92-01205 
92-11824 T G C 
93-6351 G C 
93-14620 T..G C C 
93-22330 A..G T C 
93-27687 T G C 
93-44927 
94-18310 T A G 0 
95-13536 T C GG C 
95-15299 T C G C 
95-33010 G C..Q 
Group II 89-46489 
89-47361 
89-47363 
92-19698 
92-22332 T T 
93-22326 . . .G C T.. .A 
93-47324C T I G C T 
94-36893 A C.... 
Group III 92-6725 T C G 
IA-D21 . . .G G 
Group IV 28523 . . .0 A  T 
Group V Lelystad .C.G. .C. . .C AG.C. . .A. .CTCCC.C. .CT. .CAA. .G G. .T. .C A GCGT.G. .T. . .TCCAGC, 
300 
Figure 3. (Continued) 
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Figure 3. (Continued) 
CONSENSUS MPNNNGKQQKKKK— 
Group I VR-2332 R. 
NOBLa R. 
s-pb 
ISU-P R. 
89-46448 R. 
91-4690T 
92-01205 
92-11824 R. 
93-6351 
93-14620 
93-22330 R. 
93-27687 R. 
93-44927 
94-18310 
95-13536 R. 
95-15299 R. 
95-33010 
100 
Group II 89-46489 
89-47361 
89-47363 ^ 
92-19698 .N 
92-22332 R.. QR 
93-22326 .N 
93-47324* ^ R... P S 
94-36893 I • 
Group III 92-6765 R.. 
IA-D21 .N 
Group IV 28523 N 
Group V Lelystad .AGK.QS.K.. .STAPH.N L. .AM.KS.R.-—QPR.GQA. . .K A .  . .1. . .L.QT. .S. . .Q AS 
Figure 4. Alignment of deduced amino acid sequences encoded by ORP 7 of representative PRRS viruses of antigenic groups I-V. 
The S amino acids at the amino terminal of the IS kD nucleocapsid protein are primer-derived. Dots represent residues 
identical to the consensus sequence, dashes indicate gaps introduced into the sequences, and the bold amino acids are 
group specific substitutions. *The modified-live vaccine virus RespPRRS/Repro, manufactured by NOBL Laboratories, 
Sioux Center, lA, USA. ""The modified-live vaccine virus PRIME PACPRRS, manufactured by Schering-Plough 
Animal Health Corporation, Omaha, NE, USA. ''A Canadian PRRS virus isolate. 
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COKSasus gTg7TVgF«r-.PT"H-T-vaT.Tavrtgp<;a 123 
Group I VR-2332 
NOBL® 
s-?b 
ISO-P 
89-4S448 
91-46907 
92-01205 
92-11324 
93-6351 
93-14620 
93-22330 
93-27687 
93-44927 
94-13310 
95-13536 
95-15299 
95-33010 
Group II 89-46489 P... 
39-47361 P... 
89-47363 P... 
92-19698 PS.. 
92-22332 P... 
93-22326 P . .  .  
93-47324 = SP.. .  
94-36893 -PH.. 
Group III 92-6725 P. 
IA-D21 P. 
Group rv 23523 H.. 
Group V Lelystad KV.FQ. --M. .VA -.T..SQ(as 
Figure 4. (Continued) 
The locations of these amino acid substitutions at positions 120, 122 and 70 in 
antigenic groups II, HI and IV respectively are correlated to changes in the secondary 
structure of the protein that are predicted by Chou-Fasman (CF) turns (Figure 5). 
Specifically, the carboxy terminal CF turn representing group II viruses is broader at the base 
and its apex is flatter relative to the homologous CF turn that represents group I viruses. No 
turn is present in this location for group HI viruses and the height of the CF turn representing 
the group IV virus in this location is markedly shorter than its counterparts in groups I and n. 
The shoulder in the peak representing the CF turn at position 70 in the group IV virus is 
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Figure 5. Chou-Fasman turns shown for each antigenic group are representative of all 
PRRS virus isolates that were sequenced. Note that group specific changes 
marked with arrows are located in the carboxy terminal CF turns for antigenic 
groups H and m, and in the 6th CF turn for antigenic group IV. 
noticeably narrower than the shoulder of the peaks representing the homologous CF turn in 
groups I, n, and IE. No distinct group specific differences were observed between the 4 
American antigenic groups when the deduced amino acid sequences were analyzed by the 
other parameters of the GCG package as specified in the Materials and Methods section. 
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American antigenic groups when the deduced amino acid sequences were analyzed by the 
other parameters of the GCG package as specified in the Materials and Methods section. 
Discussion 
The principal objectives of the current study were to further characterize the antigenic 
nature of the highly conserved 15 kD nucleocapsid protein of PRRS virus and to determine if 
a sufficient degree of antigenic diversity exists in this protein that could provide the basis of a 
marker system for PRRS viruses. Published data prior to the present study suggest that at 
least 5 epitopes in various combinations are associated with the IS kD nucleocapsid protein 
of American and European PRRS virus isolates. Three of these epitopes are most likely 
discontinuous because of their inability to be recognized by MAbs in Western 
immimoblotting. These epitopes are represented by MAbs SDOW 17, VO 17 [7, 26], and 
ICH5 [29]. The MAbs SDOW 17 and VO 17 represent 2 distinctly different conserved 
epitopes. The original characterization of MAbs SDOW 17 and VO 17 by Nelson et al. [26] 
demonstrated that MAb SDOW 17 reacted with all 63 American and 57 European isolates 
tested. In contrast, MAb VO 17 only recognized the American isolates. The MAb ICH5 
appears to be different from MAb SDOW 17 because it failed to react in the IFA with 3 
American isolates [16]. The 2 continuous epitopes are represented by MAbs WBE 1 and 
WBE 4 respectively [8]. Their distincmess was demonstrated by their reactivity pattern with 
a combined total of 44 European and 11 American PRRS virus isolates [8, 16]. Both MAbs 
reacted with all European isolates tested but while MAb WBE 4 did not react with any of the 
11 American isolates, MAb WBE 1 reacted with 3. 
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In addition to the 5 epitopes described above, a sixth epitope specific for the IS kD 
protein may also exist. It is continuons and is represented by MAb P3/27 which was 
originally shown to react with all 14 European and 12 American isolates tested [36]. In a 
different study [16], MAb P3/27 was shown to have the same IFA reactivity pattern as MAb 
W6E 1. In that study, both MAbs reacted with all 21 European and 3 American isolates 
tested. There are no published accoimts that clearly indicate whether or not MAb P3/27 
reacts with the 8 American isolates that were not recognized by WBE 1 [8] or that WBE 1 
reacts with the 12 American isolates recognized by P3/27 [36]. Consequently, it remains to 
be clarified whether or not MAbs P3/27 and WBE 1 represent the same or different epitopes. 
Nevertheless, the two published accounts which indicate that MAb P3/27 reacted with 15 of 
15 American isolates tested [16,36] and that MAb WBE 1 did not react with 8 different 
American isolates [8] suggest that 2 MAbs represent different epitopes. 
In the present study, 5 distinct continuous epitopes designated EpORF7-A through E 
were revealed among American isolates further contributing to our knowledge of the 
antigenic nature of the 15 kD protein of PRRS virus. The imiqueness of the individual 
epitopes was confirmed by the results of blocking and additivity ELISA assays. In the 
blocking assay (Table 4), heterologous MAbs failed to inhibit binding of MAbs representing 
each of the 5 different epitopes (p < 0.001). While in the additivity assay (Table 3) optical 
density measured following treatment of antigen preparations with MAb representing each 
epitope was significantly enhanced (p < 0.001) after additional treatment with heterologous 
MAbs but not with homologous MAbs. At least 4 of the 5 continuous epitopes were present 
in all viruses tested with the exception of the Lelystad virus which contained only EpORF7-
A as determined by both IFA and Western immunoblotting (Table 2). Consequently, it is 
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possible that EpORF7-A may represent the same epitope as P3/27. Analysis of a broad panel 
of European PRRS virus isolates will be necessary to detemiine which if any of the 
remaining 4 continuous epitopes are present in European isolates. 
In an effort to detennine the approximate locations of EpORF7-A through E in the 15 
kD protein the deduced amino acid sequences were computer analyzed using the GCG 
package. None of the parameters as described in the Materials and Methods section could be 
correlated to antigenic sites with the possible exception of Chou-Fasman (CF) profiles, as 
indicated by number, location, shape and size of CF turns. Individual CF turns are a 
reflection of secondary structure which can influence antigenicity. Unique differences in the 
CF profiles of antigenic groups n, HI and IV relative to the CF profile of group I were 
observed at locations encompassing amino acids 120,122 and 70 respectively (Figure 5). 
These amino acids represent imique group specific substitutions which appear to be 
correlated to the absence of EpORF7-B, C and D in antigenic groups n. III and IV 
respectively. This observation and the demonstration of inhibition mediated by MAbs 
representing EpORF7-E with MAbs representing EpORF7-B, C and D (Figure 2) suggest 
that the amino acid sequences representing EpORF7-B, C and D are relatively close to one 
another at the carboxy terminal end of the 15 kD protein. The absence of reciprocal or one­
way inhibition between MAbs representing EpORF7-A and EpORF7-B, C, D and E in the 
blocking assay (Table 4) suggests that EpORF7-A is spatially distant from these epitopes. 
The available data is not stifBcient to predict the probable location of EpORF7-A or 
E. However, a recent study by Rodriguez et al. [29] demonstrated the presence of a 
continuous epitope in the central region of the 15 kD protein in both a European (Olot/91) 
and an American (Quebec 807/94) PRRS virus isolate by reacting a panel of MAbs with 
fragments of recombinant 15 kD protein by Western immunoblotting. They further 
demonstrated that a highly conserved amino acid sequence extended from amino acid 50-90 
in 3 American and 2 European isolates which included the Lelystad virus. Amino acids 50-
66 were associated with the common epitope. These observations suggest that the common 
epitope described by Rodriguez et al. could be identical to EpORF7-A. Competitive assays 
between MAbs representing EpORF7-A and the common epitope described by Rodriguez et 
al. may answer this question. 
The degree of antigenic diversity demonstrated among American isolates in the 
present study was less than expected. The distribution of the 5 epitopes associated with 
American PRRS isolates permitted their subdivision into 4 antigenic groups that were 
distinctly different from the European Lelystad virus. However, antigenic groups I and n 
represented 84.1% and 11.6% of all isolates tested while groups m and IV represented the 
remaining 4.3% of the isolates. This limited antigenic diversity among American PRRS 
viruses as revealed by the panel of MAbs specific for the 15 kD protein indicates that a 
useful marker system will require a broader panel of MAbs representing epitopes of other 
PRRS virus proteins. Alternatively, more sensitive MAb based methodologies could be used 
such as the signature analysis that was originally described by Wands et al. [32]. This 
technique uses a panel of MAbs to generate individual antigen binding curves that reflect 
both the affinity by which individual MAbs bind to an epitope and the density of epitopes on 
the surface of the virus. 
The reliable use of MAbs to identify PRRS virus isolates will also depend on the 
stability of the epitopes that they represent. Previous work by Le Gall et al. [16,17] failed to 
demonstrate any antigenic change in the 15 kD protein following one or two passages of 6 
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virus isolates through pigs. However, they did observe antigeiiic change in an epitope of 
glycoprotein 3 in 2 of the 6 isolates. Consequently, the relative stability of individual 
epitopes that form the basis of a virus identification system must be thoroughly evaluated. 
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CATEGORIZATION OF NORTH AMERICAN PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUSES; EPITOPIC PROFILES OF THE N, M, 
GPS AND GP3 PROTEINS AND SUSCEPTIBILITY TO NEUTRALIZATION 
A paper in press in the Archives of Virology 
L. Yang, M.L. Frey, K.-J. Yoon, J.J. Zimmerman and K.B. Piatt 
Summary. Eleven epitopes were identified by murine monoclonal antibodies (MAbs) that 
represented the N, M, GPS and GPS proteins of the North American (NA) porcine 
reproductive and respiratory syndrome (PRRS) virus, KY 35 (NVSL 46907). Three 
discontinuous epitopes of the N and M proteins were designated EpORF7-Fd through Hd and 
EpORF6-Ad through Cd. Five continuous epitopes of the GPS and GPS proteins were 
designated EpORFS-A through C and EpORFS-A and B. The MAbs representing EpORFS-
C and EpORF6-A and B had neutralizing activity. The MAbs representing the above 
epitopes, except EpORF7-Gd and Hd, expanded the virus marker system described in a 
previous study in which a panel of 69 NA viruses and the Lelystad virus were categorized 
into 5 antigenic groups, lis through Vj5 based on the presence or absence of 5 continuous 
epitopes of the N protein. Antigenic groups I15 and His, which represented 84.7 and 11.6% 
of all viruses tested, were categorized further into 9 and 4 subgroups, respectively. The 
remaining NA viruses and the Lelystad virus were distributed among 4 groups, one of which 
was represented by 2 subgroups. Significant (P<0.05) differences in senativity to 
neutralization of 28 viruses representing 6 antigenic groups by the S neutralizing MAbs 
suggested that sensitivity to neutralization may also be of value in categorizing PRRS 
viruses. 
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Introduction 
Porcine reproductive and respiratory syndrome (PRRS) virus is the cause of an 
economically significant disease of swine worldwide. The virus was initially isolated fi'om 
European swine in 1990 [41] and designated the Lelystad virus. Subsequently, the PRRS 
virus ATCC VR-2332 was isolated fi'om North American swine [2, 6]. Effective control of 
this disease, both with and without the use of vaccines, is dependent on understanding the 
ecology of PRRS virus. Consequently, a virus marker system was developed for xhis purpose 
in a previous study [43]. This marker system was based on the presence or absence of 5 
continuous epitopes of the 15 kD nucleocapsid protein in individual viruses. It permitted the 
categorization of a panel of 69 North American (NA) PRRS viruses into 4 antigenic groups 
designated I15 through IV15. However, 84.7% of the isolates were represented by antigenic 
group Ii5 and 11.6% were represented by antigenic group II15. This unequal distribution of 
the majority of field viruses into 2 antigenic groups limited the usefiilness of the marker 
system and clearly indicated that a system based on a broader distribution of epitopes was 
required. 
The PRRS virus is a member of the Arteriviridae [4, 34]. Other viruses of this family 
include lactate dehydrogenase-elevating virus (LDV) of mice, equine arteritis virus (EAV) 
and simian hemorrhagic fever virus (SHFV) [4, 34]. The genome of the arteriviruses is a 
single strand of positive sense RNA that varies from 12.7 to 15.7 kb in size [36]. The 
genomic organization of the arteriviruses was first described for EAV by Den Boon et al. [9] 
who identified the presence of a nested set of 8 open reading fi^ames (ORFs). More recently, 
a region between ORF lb and ORF 2 of the EAV genome that encodes a 67 amino acid 
structural protein has been identified [37]. This region of the EAV genome has been 
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designated ORF 2a and the fonner ORF 2 has been renamed ORF 2b. The genome of PRRS 
virus is 15 kb in size. Eight ORFs have been identified and are designated la, lb, and 2 
through 7 [25]. An additional ORF equivalent to ORF 2a of EAV may also exist in the 
PRRS virus genome [37]. 
The ORFs la and lb of PRRS virus encode nonstructural proteins associated with 
viral replicase activity [25]. The ORFs 2 through 7 encode structural proteins with molecular 
masses of30, 45, 31, 25, 19 and 15 kD respectively, which are designated GP2, GP3, GP4, 
GP5, M and N respectively [7, 25, 26,27, 39]. The N protein is associated with the 
nucleocapsid. The GP2, GP3, GP4, GP5 and M proteins are associated with the viral 
envelope. The GP2 and GP5 proteins are counterparts of the Gs and GL proteins of EAV [10, 
36]. The GPS protein of PRRS virus is the major envelope protein and is a primary target of 
neutralizing antibody [32, 33,40]. The GP4 protein is a minor envelope protein and is also a 
target of neutralizing antibody [28, 39, 40]. The GP2 protein of European viruses has not 
been demonstrated in NA viruses to date. 
Both genetic and antigenic differences have been demonstrated between and among 
European and NA PRRS viruses. Murtaugh et al. [30] compared deduced amino acid 
sequences of ORFs 2 through 7 of the NA virtis ATCC VR-2332 to the Lelystad virus. The 
identity between ORFs 2 through 7 of these 2 viruses ranged from 58% to 78%. Genetic 
variability between and among European and NA PRRS viruses has been observed by other 
investigators [1, 12, 16, 19, 21, 22, 24, 38, 43], These genetic differences are also reflected 
by the distribution of protein-specific epitopes among viruses. 
At least 5 and as many as 7 distinct continuous epitopes are associated with the N 
protein. Five of these epitopes, designated EpORF7-A through E, are distributed among NA 
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viruses [43]. Two of these epitopes, EpORF7-A and B are also present on the Lelystad virus. 
Monoclonal antibodies WBE 1 [11] and P3/27 [42] serologically react with viruses of both 
North American and European origin and may represent 2 additional continuous epitopes. In 
addition, at least 2 discontinuous epitopes are represented by MAb SDOW17 which reacts 
with both NA and European viruses including the Lelystad virus, and MAbs V017 and 
EP147 which react with NA viruses but not with the Lelystad virus [31]. An additional 
discontinuous epitope may be represented by MAb 1CH5 that has only been shown to react 
with European viruses [35]. 
Four continuous epitopes have been identified for the M protein based on sero-
reactivity patterns of MAbs. Two of these epitopes are represented by MAbs 122.9 and 
126.3 [39]. Both MAbs react with Lelystad virus but only 122.9 reacts with the NA virus, 
ATCC VR-2332. The other 2 epitopes are represented by MAb 2C12 [20] and by MAb 
L\FK3 or 6 [8]. Neither of these 2 epitopes is present on the Lelystad virus. No 
discontinuous epitopes of this protein have been described. 
At least 4 continuous epitopes of the GPS protein have been identified. Two epitopes 
described by Pirzadeh and Dea [33] were identified by the sero-reactivity patterns of 2 
different groups of neutralizing MAbs. The first group was represented by MAbs 2A5, 3A12 
and ICIO. The second group was represented by MAbs IAF8A8 and 1B8. Both MAb 
groups sero-reacted with the same panel of NA PRRS viruses with the exception that the NA 
virus, ATCC VR-2332 was only recognized by the second group. Neither group of MAbs 
recognized the Lelystad virus. A third continuous epitope that did not induce neutralizing 
antibody was detected by Zhang et al. [47] in NA viruses. These investigators also described 
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2 discontinuous epitopes among NA viruses, one of which induced neutralizing antibody. A 
fourth continuous epitope of the GPS protein has been described by Weiland et al. [40]. This 
epitope was shown to be a target of neutralizing antibody and was only detected in a clone of 
the Dutch isolate 110, but not in any of 12 NA viruses tested or the Lelystad virus. 
At least 3 and as many as S continuous epitopes have been associated with the GP4 
protein of European viruses as determined by sero-reactivity patterns of MAbs and the 
presence or absence of neutralizing activity of these MAbs. Two epitopes were represented 
by the neutralizing MAbs P3/35, and P7/bl-7 [40, 42]. A third epitope was represented by 
the non-neutralizing MAb, P7/bl-2 [40,42]. Monoclonal antibodies 122.68 and 121.4 
described by Meulenberg et al. [28] may represent additional continuoxis epitopes [18, 28]. 
In addition, Zhang et al. [47] described a group of 4 MAbs that represented at least 1 
discontinuous epitope of NA viruses. 
At least 6 continuous epitopes have been associated with the GP3 protein. Three 
epitopes are represented by MAb WBE 2 [11], and MAbs P7/a2-55 and P7/b2-14 [42]. All 3 
epitopes appear to be restricted to European viruses including the Lelystad virus. In 2 
separate comparative studies, MAb WBE 2 did not react with any of 11 NA viruses tested, 
and MAbs P7/a2-55 and P7/b2-14 did not react with any of 12 NA viruses tested [11, 18]. 
The remaining 3 epitopes are represented by MAbs P7/al-19, P9/a3-20, and P9/b3-l and are 
associated with both NA and European viruses [42]. All 3 MAbs reacted with both the 
Lelystad virus and the NA viruses tested. A fourth epitope associated with both the Lelystad 
virus and NA viruses may be represented by the MAb designated 122.14 by van Nieuwstadt 
et al. [18, 39]. No discontinuous epitopes of the GP3 protein have been reported. 
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In the present study a panel of MAbs was developed to further characterize the 
antigenic nature of the N, M, GPS and GPS proteins of NA PRRS viruses and to identify 
specific epitopes that serve as targets for neutralizing antibody. These MAbs were then used 
to determine if the usefulness of the virus marker system previously described could be 
enhanced. 
Materials and methods 
Viruses and cells 
Sixty-nine PRRS virus isolates of North American origin and the Lelystad virus of 
European origin used in the present study were also used in an earlier study [43]. The NA 
PRRS viruses included ATCC VR-2332, ISU-P (ATCC VR-2402), 2 modified-Uve vaccine 
viruses, RespPRRS/Repro (Boehringer Ingelheim/NOBL Laboratories, Sioux Center, Iowa, 
USA) and PRIME PAC PRRS (Schering-Plough Animal Health Corporation, Omaha, 
Nebraska, USA). All field isolates were isolated and propagated at least one time in MARC-
145 cells [17]. Vaccine viruses used in the present study were propagated one time in 
MARC-145 cells. Virus inoculated and iminoculated MARC-145 cells were propagated and 
maintained in Dulbecco's modified Eagle's mediimi (DMEM) supplemented with 10% and 
2% fetal bovine serum respectively at 37 °C in a 5% carbon dioxide atmosphere. 
Antigen preparations 
Two antigen preparations were produced as previously described [43] for use in 
Western immunoblotting (WI) and the indirect enzyme-linked immunosorbent assay 
(ELISA). A detergent solubilized lysate of MARC-145 cells infected with PRRS virus, KY 
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35 was used in both WI and the ELISA. Semi-ptirified whole virus preparations derived 
from MARC-145 cells infected with virus KY35 were used only in WI. 
Antigen for radioimmunoprecipitation (RIP) was prepared as described by Burleson 
et al. [3]. Briefly, MARC-145 cell monolayers in 25 cm^ flasks were inoculated with PRRS 
virus KY 35 at a multiplicity of infection (MOI) of 5 or left as uninoctilated controls. 
Medium was removed from virus infected and uninfected cells 36 h after virus or sham 
inoculation. The cell monolayers were washed 3 times with serum-free and methionine-free 
DMEM and subsequently replenished with the same medium at the rate of 2 ml per flask. 
After 1.5 h of incubation at 37 °C the medium was again replaced with 2 ml of serum-free 
DMEM supplemented with 40 jiCi of ^^S-methionine per ml (ICN Biomedical, Inc., Costa 
Mesa, CA, USA) and incubated for an additional 5 h. The medium was removed and cell 
monolayers were washed once with lysis buffer (0.25 M Tris/0.11 M Tricine buffer, pH 8.6, 
containing 0.14 mM calcium lactate and 1% (V/V) TritonX-100). Virus-infected and 
uninfected cells were treated with 10 volumes of cold lysis buffer for 15 min at 4 ®C. Cell 
lysates were centrifuged for 4 min at 10,000 x g. The supematant fluids containing ^^S-
methionine labeled viral and cell control antigen were collected and stored at -80 °C until 
used. 
Antigen for mouse inoculation was prepared from MARC-145 cells singly infected at 
a MOI of 5 with PRRS viruses ATCC VR-2332 or KY 35. Four days later, virus infected 
cells were frozen and thawed 2 times at -80 °C and +37 ®C. The suspension was centrifuged 
at 2,000 X g for 30 min at 4 °C. Supematant fluid containing virus was collected and stored at 
-80 °C until used. 
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Western immunoblotting 
Virus and cell control antigens were mixed 1:1 with sample buffer (62.5 mM Tris-
HCl, pH 6.8, containing 10% glycerol, 2% SDS, 5% 2-mercaptoethanol and 100 ng 
bromphenol blue) and boiled for 3 min. Individual proteins were separated by SDS-PAGE 
on 14% acrylamide gels. The separated proteins were electroblotted onto nitrocellulose 
membranes. The nitrocellulose strips were immersed overnight in 0.01 M phosphate 
buffered saline (PBS) containing 5% (W/V) skim milk to block non-specific binding by 
antibody. Subsequently, nitrocellulose strips were incubated 2 h at 37 °C with supernatant 
fluids of hybridoma cell cultures or ascitic fluids containing specific MAbs. The 
nitrocellulose strips were then washed 4 times in PBS containing 0.05% Tween 20 and 
treated for 1.5 h at 37 °C with horseradish peroxidase conjugated goat anti-mouse IgG 
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, USA) diluted 1:1000 in PBS. 
Serological reactivity between MAbs and specific protein bands was visualized by adding the 
substrate 3, 3', 5, 5'-tetramethylbenzidine (Kirkegaard & Perry Laboratories, Inc., 
Gaithersburg, MD, USA) to the strips after a final washing. 
Radioimmunoprecipitation (RIP) 
Eighty ^1 of virus and cell control antigens were separately incubated on a roller 
apparatus overnight with 4 fil of ascitic fluid containing specific MAbs. The antigen-
antibody complexes were collected by adding 50 ^1 of protein A-Sepharose CL-4B beads 
(Sigma Company, St. Louis, MO, USA) to the mixtures and incubating at 4 °C for an 
additional hour. The precipitates were washed 3 times in lysis buffer, 3 times in PBS, 
resuspended in an equal volume of the sample buffer described above and boiled for 3 min. 
Individual ^^S-methionine labeled proteins were separated by SDS-PAGE in 14% acrylamide 
95 
gels. Electrophoresed gels were impregnated with 2,5-diphenyloxazole scintillate in 
dimethyl sulfoxide, washed 3 times with deionized water, dried under vacutmi and exposed 
to XAR5 film (Eastman Kodak Co, Rochester, NY) at -80 °C for 3 to 5 days. 
Additivity and blocking assays 
The additivity assay and blocking ELISA were used to confirm the epitope specificity 
of individual MAbs with unique sero-reactivity patterns. The additivity assay originally 
described by Friguet et al. [14] was conducted as modified by Yang et al. [43] using affinity 
purified MAb from ascitic fluid. Serological reactivity between MAbs of unknown epitope 
specificity and antigen, and homologous MAbs and antigen was expressed as a corrected 
optical density (OD). Mean additivity values (AVs) for MAb interactions were calculated by 
the formula: 
Corrected OD MAb a + b 
AV X 100% 
(Corrected OD MAb a) + (Corrected OD MAb b) 
where MAb "a" and "6" are any 2 MAbs tested for additivity. The theoretical AVs of 
homologous and heterologous MAb interactions should approach 50 and 100% respectively. 
Differences between AVs were analyzed for significance by Student's Mest. 
The blocking ELISA originally described by Cecilia et al. [5] and modified by Yang 
et al. [43] was conducted using afGnity purified MAbs from ascitic fluid. Percent binding 
was calculated for each MAb interaction by comparing the corrected ODs generated in viral 
and cell antigen preparations treated with blocking MAb to the corrected ODs generated 
following treatment of antigen and cell controls with diluent. Dififerences between mean 
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percent bindings representing at least 3 replications for individual MAbs were compared for 
significance by the one-way analysis of variance. Significant (P < 0.05) inhibition of binding 
by blocking MAbs was considered to be an indication of identity or interference by adjacent 
or overlapping epitopes. 
Virus neutralization 
The constant virus varying antibody protocol was used to detect neutralizing activity 
of MAbs in ascitic fluids as previously described [43] with the exception that PRRS virus 
KY 35 was used as antigen. Neutralization titers were expressed as the reciprocal of the 
highest dilutions of MAbs that completely inhibited CPE formation. 
The constant antibody varying virus protocol was used to detect susceptibility of 
viruses to neutralization by polyclonal swine serum and neutralizing MAbs. Individual 
viruses were serially diluted 10-fold in DMEM supplemented with 2% FBS and antibiotics. 
Fifty fil aliquots of each virus dilution and equal quantities of swine antiserum or ascitic fluid 
were added together in duplicate wells of 96-well microliter plates and incubated at 37 °C for 
1 h. One hundred p.1 of a MARC-145 cell suspension diluted to contain 10^ cells was added 
to each well including wells representing virus and cell controls. Microliter plates were 
incubated for 5 days at 37 °C and observed for CPE. Titers of individual viruses in the 
presence and absence of specific neutralizing MAbs were expressed as TCID50 and 
neutralization indices were calculated. Assays were replicated 4 times. 
MAb production 
Monoclonal antibodies were generated as previously described [43] with the 
exception that a protocol to establish partial immimotolerance [23] to the N protein of PRRS 
97 
vims was adapted. PRRS viruses ATCC VR-2332 and KY 35 were selected from 34 NA 
vimses. These 2 viruses were the most susceptible and the most resistant, respectively to 
neutralization by polyclonal swine serum raised against ATCC VR-2332. However, all 5 
continuous epitopes of the N protein [43] were present in both viruses. Consequently, ATCC 
VR-2332 was used to partially immunotolerize mice to the N protein and KY 35 was 
subsequently used in the generation of MAbs. 
Eight-week-old BALB/c mice were injected intraperitoneally with 0.5 ml of virus 
suspension diluted to contain 10® TCIDso of PRRS virus ATCC VR-2332. Ten minutes later, 
mice were injected intraperitoneally with cyclophosphamide at the rate of 100 mg/kg (Sigma 
Chemical Company, St. Louis, MO, USA) prepared in PBS. Mice were injected a second 
and third time with cyclophosphamide at 24 h and 48 h after the first injection. This 
treatment was repeated 2 times at 2 week intervals. Three weeks after the last tolerizing 
treatment, mice were injected intraperitoneally with 0.5 ml of adjuvanted viral antigen 
prepared by adding together equal volumes of aluminum hydroxide adjuvant (Armour 
Pharmaceutical Company, IL, USA) and virus suspension containing 10 TCIDso/mlof 
PRRS vims KY 35. Mice were injected with adjuvanted antigen a second time 2 weeks later 
and maintained for 2 to 3 weeks before being used for hybridoma cell production. Mice were 
injected intraperitoneally with 0.5 ml of KY 35 virus suspension without adjuvant 3 days 
before harvesting spleens. 
Characterization of PRRS viruses 
The sero-reactivity of the 69 NA PRRS viruses and the Lelystad virus was 
determined for each MAb using the indirect immunofluorescence assay as described by Frey 
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et al. [13]. Individual viruses with common epitope profiles were subsequently categorized 
into subgroups within each antigenic group. 
Twenty eight NA viruses representing antigenic groups IV15 and VI15, and 15 
subgroups representing antigenic groups I15, His and IIIis were evaluated for their relative 
sensitivity to neutralization by MAbs ISU19A1,19B1 and 25C1 using the constant antibody 
varying virus method. Differences between mean NIs of individual viruses were analyzed 
for significance by the one-way analysis of variance. 
Results 
Generation of MAbs and identificatioii of epitopes 
Twenty-one antibody-secreting hybridoma cells were generated fix)m 5 fiisions. 
These MAbs represented the N, M, GP3 and GPS proteins of PRRS virus, respectively. 
Identification of epitopes 
N protein 
Twelve (57%) of the 21 MAbs were specific for the N protein. Two of the 12 MAbs 
represented the continuous epitopes EpORF7-A and B that were previously described [43]. 
Their identity was determined by sero-reactivity in WI and their sero-reactivity with the 
panel of 70 PRRS viruses (Table 1). The remaining 10 MAbs reacted with native antigen in 
RIP (Fig.l) but not with denatured antigen in WI, indicating that these 10 MAbs recognized 
discontinuous epitopes. Sero-reactivity with the panel of 70 PRRS viruses (Table 1) 
indicated that these 10 MAbs represented 3 discontinuous epitopes designated EpORF7-Fd, 
Gd and Hd and were represented by MAbs ISUlSFdl through Fd3, ISUlSGdl through Gd4 
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Table 1. Categorization of 70 PRRS viruses by sero-reactivity with monoclonal antibodies 
representing 5 continuous and 3 discontinuous epitopes of the N protein as 
determined by the indirect immunofluorescence antibody test 
Monoclonal antibody group * 
Antigenic 
group 
No. of 
PRRS viruses A B c D £ Fd" Gd Hd 
Il5 57' + + 4- + + 
n,5 8 - + •r -t-
niis 2 -f- - -h 4- + + 
IV,S 1 -h - -r + + 
V,5 LV -H 
- -
- -
-
-f 
VI,s I 4- 4- -t- - -r 
* Monoclonal antibody groups A through Hd represent specific epitopes of the N protein EpORF7-A through 
Hd, respectively 
** The lowercase "d" indicates that the epitopes represented by these 3 groups of monoclonal antibodies are 
discontinuous 
' Includes PRRS viruses KY 35 (NVSL 46907), ATCC VR-2332, ISU-P (ATCC VR-2402, the prototype virus 
used for the inactivated vaccine PRRomiSe by Bayer Corporation, Shawnee Mission, KS, USA) and the 2 
modiiied-live vaccine virus strains, PRIME PAC PRRS (Schering-Plough Animal Health Corporation, 
Omaha, NE, USA), and RespPRRS/Repro (Boehringer Ingelheim/NOBL Laboratories, Sioux Center, LA, 
USA) 
The Lelystad virus 
' Weak positive reaction 
M protein 
Three of the 21 MAbs represented the M protein. They were designated MAbs 
ISU19A1, B1 and CI and were shown to represent 3 discontinuous epitopes designated 
EpORF6-Ad, Bd and Cd, respectively. The imiqueness of EpORF6-Cd fixim EpORF6-Ad 
and Bd was demonstrated by sero-reactivity patterns of the 3 MAbs with the panel of 70 
PRRS viruses (Table 2). The sero-reactivity patterns of MAbs ISU19A1 and B1 with this 
panel of viruses were the same. However, these 2 MAbs were shown to represent different 
epitopes by the Veterinary Diagnostic Laboratory at South Dakota State University (Data not 
shown). Monoclonal antibody ISU19A1 sero-reacted with PRRS viruses 92-23224 and 98-
100 
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Fig. 1. Radioimmunoprecipitation. A, B, C and D represent treatments with 
monoclonal antibodies ISU45A1 through Bl, ISU25A1 through CI, ISU19Adl 
through Cdl, and ISU15A1 through Hdl, respectively. The left lane of each 
panel represents virus antigen derived from MARC-145 cells infected with 
PRRS virus KY 35 (NVSL 46907). The right lane of each panel represents 
cell control antigen. Molecular weight markers (in kilodalton) are indicated 
in the left margin 
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Table 2. Characterization of 70 PRRS viruses by sero-reactivity with monoclonal antibodies 
specific for the N, M, GPS and GPS proteins as determined by the indirect 
immunofluorescence antibody test 
Monoclonal antibodies 
Antigenic 
group* 
Sub 
group 
iNo. or 
PRRS 
viruses 
ISU19AI 
and Bl ISU19CI ISU25A1 ISU25BI ISU25C1 ISU45A1 ISU4SB1 
Il5 1 17 = + + + + 
2 30"^ -i-
- -
3 4 + + + +• • - •r 
4 1' 
-
•r 
- -
5 1^ - - + -f- - -
6 1 4- •4-
-
7 1 + -f- -r -
-
8 1 - 4. - -
9 1 + 
- -
-
+ 
n,5 1 5 -f •*-
2 1 -f + 
-
3 I - -f-
4 I 
-
-
+ •r 
-
111,5 1 1 -t- + 
2 1 
- - -
rv.5 1 I -r 4- - -i-
V,5 1 LV* 
-
-
- -
-
- -
VI,5 I I + -h -f 
' Based on the distribution of continuous and discontinuous epitopes of the N protein 
'' Monoclonal antibody ISU19B1 is considered to be different from ISU19AI because it did not react with PRRS viruses 92-
23224 and 98-15995 when tested at South Dakota State University, Brookings, USA 
= Includes PRRS virus KY 35 (NVSL 46907) 
Includes ATCC VR-2332 and the modified-live vaccine virus strain RespPRRS/Repro (Boehringer Ingelheim/NOBL 
Laboratories, Sioux Center, lA, USA) 
' The virus ISU-P (ATCC VR-2402), the prototype virus used for the inactivated vaccine PRRomiSe (Bayer Corporation, 
Shawnee, KS, USA) 
^ The modified-live vaccine vims strain PRIME PAG PRRS (Schering-Plough Animal Health Corporation, Omaha, NE, 
USA) 
® The Lelystad virus 
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15995 but MAb ISU19B1 did not. The discontinuous nature of these 3 epitopes prevented 
further confirmation of their uniqueness by the blocking and additivity assays. All 3 of these 
MAbs were of the IgGl subclass and had kappa Ught chains. 
GPS protein 
Three of the 21 MAbs represented the GPS protein as determined by both WI and 
RJP. These MAbs were designated ISU25A1, B1 and CI and were shown by their sero-
reactivity patterns with the panel of PRRS viruses to represent 3 continuous epitopes that 
were designated EpORFS-A, B and C (Table 2). The distinctness of each epitope was further 
demonstrated by both additivity and blocking assays (Tables 3 and 4). The differences 
Table 3. Epitopic analysis of the GPS protein of PRRS virus KY 35 (NVSL 46907) by the 
additivity test using 3 monoclonal antibodies (MAbs) ISU2SA1, B1 and CI 
Test MAb 
Added MAb ISU25AI ISU25B1 ISU25C1 
None 0.58' 0.52 0.41 
ISU25A1 54.3% (0.63/1.16)" 
ISU25B1 86.4% (0.95/1.10) 
54.8% 
(0.57/1.04) 
ISU25C1 86.2% (0.94/1.09) 
92.5% 
(0.86/0.93) 
52.4% 
(0.43/0.82) 
' Optical density was measured at 405 mn. 
** Additivity values (AVs) expressed as binding percent were calculated using the foimula: 
Corrected OD MAb a + 6 
AV = X 100% 
(Corrected OD MAb a )  + (Corrected OD MAb b )  
where MAbs "a" and "b" are any 2 MAbs tested for additivity. 
The measured OD values and theoretical sum of OD values of any 2 MAbs are indicated in parenthesis. AVs = 
50% indicate identity. 
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Table 4. Epitopic analysis of the GPS protein of PRRS virus KY 35 (NVSL 46907) by the 
blocl^g ELISA using 3 monoclonal antibodies (MAbs) ISU25A1, B1 and CI 
Blocking MAb 
Biotinylated MAb 
ISU25A1 ISU2SB1 ISU25C1 
ISU25A1 +• 
ISU25B1 + 
ISU25C1 - - + 
^ Significant (P < 0.001) inhibition by blocking MAbs. The mean percent binding for homologous 
MAb interactions at the lowest dilution (1:10) of blocking MAbs was 33.5 ± 2.6 and ranged from 
30.5 ±3.2 to 35.6 ±2.1. 
** No inhibition by blocking MAbs. The mean percent binding for heterologous interactions at the 
lowest dilution (1:10) of blocking MAbs was 86.1 ± 2.4 and ranged from 82.8 ± 1.9 to 88.9 ± 1.5. 
between homologous and heterologous interactions in both assays were significant (P < 
0.001). The mean AVs of the 3 homologous MAb interactions in additivity assays was 53.8 
± 1.4% and ranged from 52.4 to 54.8%, indicating identity. The mean AVs of the 3 
heterologous interactions was 88.4 ± 2.8% and ranged from 86.8 to 92.5 %, indicating 
nonidentity. Similarly, the mean percent binding in homologous interactions was 33.5 ± 
2.6% and ranged from 30.5% to 35.6%, indicating identity. The mean percent binding in 
heterologous interactions was 86.1 ± 2.4% and ranged fix)m 82.8% to 88.9%, indicating 
nonidentity. All 3 MAbs were of the IgGl subclass with lambda light chains. 
GP3 protein 
Three of the 21 MAbs represented the GP3 protein as determined by both WI and 
RIP. These MAbs were designated ISU45A1, A2 and B1 and were shown by their sero-
reactivity patterns with the panel of 70 PRRS viruses to represent 2 continuous epitopes that 
104 
were designated EpORF3-A and B (Table 2). The distinctness of the 2 epitopes was defined 
further by both additivity and blocking assays. The mean AV observed following interaction 
of MAbs ISU45A1 and A2 was 58.6 ± 1.5% indicating identity (Table 5). This AV was 
significantly (P < 0.001) different from the AV observed following the interaction of MAbs 
ISU45A1 or A2 with MAb ISU45B1. These values were 92.3 ± 2.0% and 94.9 ± 1.8% 
indicating nonidentity. Similarly, percent binding generated by the reciprocal interactions 
between MAbs ISUAl and A2 was 30.5 ± 3.0 and 31.7 ± 1.8 % which indicated that 
significant (P<0.001) blocking occurred (Table 6). These percent binding values were 
significantly different (P < 0.001) from those that were observed following reciprocal 
Table 5. Epitopic analysis of the GP3 protein of PRRS virus KY 35 (NVSL 46907) by the 
additivity test using 3 monoclonal antibodies (MAbs) ISU45A1, B1 and CI 
Test MAb 
Added MAb ISU45A1 ISU45A2 ISU45BI 
None 0.52* 0.59 0.45 
ISU45A1 52.9% (0.55/1.04)" 
ISU45A2 58.6% (0.65/1.11) 
57.6% 
(0.68/1.18) 
ISU45B1 94.9% (0.92/0.97) 
92.3% 
(0.96/1.04) 
56.7% 
(0.51/0.90) 
' Optical density was measured at 405 nm. 
^ Additivity values (AVs) expressed as binding percent were calculated using the formula: 
Corrected OD MAb a+ b 
AV = X 100% 
(Corrected OD MAb a) + (Corrected OD MAb b) 
where MAbs "a" and "6" are any 2 MAbs tested for additivity. 
The measured OD values and theoretical sum of OD values of any 2 MAbs are indicated in 
parenthesis. AVs = 50% indicate identity. 
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Table 6. Epitopic analysis of the GPS protein of PRRS vims KY 35 (NVSL 46907) by the 
blocldng ELISA using 3 monoclonal antibodies (MAbs) ISU45A1, A2 and B1 
Blocking MAb 
Biotinylated MAb ISU45A1 ISU45A2 ISU45B1 
ISU45A1 + -
ISU45A2 + + -
ISU45B1 _b - + 
Significant (P< 0.001) inhibition by blocking MAbs. The mean percent binding for homologous 
MAb interactions at the lowest dilution (1:10) of blocking MAbs was 32.9 ± 2.4 and ranged from 
31.9 ± 2.5 to 34.6 ± 2.4. The mean perccnt bindings for interactions of MAbs 1SU45A1 and A2 
were 30.5 ± 3.0 and 31.7 ± 1.8. 
No inhibition by blocking MAbs. The mean percent bindings for interactions of biotinylated MAbs 
ISU45A1 and A2 with blocking MAb ISU45B1 were 85.6 ± 1.6 and 84.8 ± 2.7. The mean percent 
bindings for interactions of biotinylated MAb ISU45B1 with blocking MAbs ISU45A1 and A2 
were 89.6 ± 2.0 and 90.5 ± 2.3. 
interactions between MAbs ISU45A1 and A2 with MAb ISU45B1. The mean percent 
binding for interactions of biotinylated MAbs ISU45A1 and A2 with blocking MAb 
ISU45B1 was 85.6 ± 1.6% and 84.8 ± 2.7%, indicating nonidentity. The mean percent 
binding for interactions of biotinylated MAb ISU45B1 with blocking MAbs ISU45A1 and 
A2 was 89.6 ± 2.0% and 90.5 ± 2.3%. These observations indicated that the epitope 
represented by MAbs ISU45A1 and A2 was diiferent from the epitope represented by MAb 
ISU45B1. All of the GPS specific MAbs were of the IgGl subclass with kappa light chains. 
Categorization of NA PRRS viruses 
Monoclonal antibodies that represented 9 of the 11 epitopes identified for the NA 
PRRS vims, KY 35 expanded the vims marker system that was initially based on the 
distribution of 5 continuous epitopes of the N protein among viruses. Antigen group VIis 
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was created when EpORF7-Fd was not detected in a virus fonnerly of group I15 and as a 
result increased the number of antigenic groups representing NA viruses from 4 to S (Table 
1). The use of the remaining 8 MAbs further subdivided antigenic groups into subgroups 
(Table 2). Antigenic group lis was represented by 9 subgroups. Subgroups 1, 2 and 3 of I15 
were represented by 17 (24.6%), 30 (43.5%) and 4 (5.8%) of all NA PRRS viruses tested. 
The remaining 6 subgroups of I15 were represented by single viruses. Antigenic group His 
was represented by 4 subgroups. Subgroup 1 of this group was represented by 5 viruses and 
the remaining 3 subgroups were represented by single viruses. Antigenic group IDis was 
represented by 2 subgroups, each containing single viruses. Antigenic group IV15 was 
represented by a single NA virus while antigenic group V15 was represented by the Lelystad 
virus. This categorization of NA PRRS viruses by epitopic profiles also permitted 
differentiation of vaccine viruses fiY>m field isolates. North American PRRS viruses were 
also distinguished from the Lelystad virus which shared only 2 epitopes, EpORF7-A and Hd, 
in common with NA viruses used in this study (Table 7). 
Susceptibility of viruses to neutralization by MAbs 
Monoclonal antibodies ISU19A1, 19B1 and ISU25C1 which neutralized PRRS virus 
KY 35 were used to compare the relative susceptibility of NA PRRS viruses to 
neutralization. The mean neutralization titer of the ascitic fluid representing these 3 MAbs 
was 4, 8 and 4 respectively. The variation in sensitivity to neutralization of the 28 viruses 
that represented antigenic groups IV15 and VI15 and the 15 subgroups of antigenic groups lis. 
His and DIis was represented by continuums (Figure 2). The differences between the mean 
neutralization indices of specific groups of viruses at the ends these continuimis were 
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Table 7. Epitope profiles of selected PRRS field viruses and vaccine strains as determined 
by a panel of monoclonal antibodies specific for the GP3, GPS, M and N proteins 
EpORF3-* EpORFS- EpORF6- EpORF7-
PRRS Antigenic 
virus group/suDgroup 
A B A B c Ad** Bd Cd A B C D E Fd Gd Hd 
K Y 3 5  1,5/1 * + -4- + + + + + 
ISU-P = 1,5/4 - -i- •4- + -f- - ^ ' -4- + + 
VR-2332 1,5/2 - -f- -t- -t- + + -¥• + 
Vaccinal ^ 1,5/2 - + + 4- -f 4- 4- + + + 
Vaccine 2 " 1.5/5 - -t- 4* - - - + 
r
 
<
 
V.5/1 -f 
" EpORF3-A and B, EpORF5-A, B, and C, EpORF6-Ad, Bd and Cd, and EpORF7-A through Hd represent 
epitopes of the GPS, GPS, M and N proteins, respectively 
*' The lowercase "d" indicates a discontinuous epitope 
The vims ISU-P (ATCC VR-2402) is the prototype virus used for the inactivated vaccine PRRomiSe (Bayer 
Corporation, Shawnee Mission, KS, USA) 
The modified-live vaccine virus RespPRRS/Repro (Boehringer Ingelheim/NOBL Laboratories, Sioux Center, 
lA, USA) 
° The modified-live vaccine virus PRIME PAC PRRS (Schering-Plough Animal Health Corporation, Omaha, 
NE, USA) 
^ The Lelystad virus 
significant (P<0.05) and ranged ft^om 1.78 for viruses treated with MAb ISU19B1, to 0.85 
and 0.75 for viruses treated with MAbs ISU19A1 and 25C1 respectively. Viruses IA-D21 of 
group nils/subgroup 2 and NVSL 22332 of group Iis/subgroup 2 were among the most 
resistant to neutralization by all 3 MAbs. In contrast, viruses ATCC VR-2332 and NVSL 
46448 of group Iis/subgroup 2, NVSL 9257 of group Iis/subgroup 3, and NVSL 6725 of 
group rVi5 were among the most susceptible to neutralization. 
Fig. 2. Susceptibility of PRRS viruses to neutralization mediated by monoclonal antibodies 
(MAbs) ISU19A1, B1 and 25C1 using constant concentrations of MAbs and varying virus 
dilutions. No significant differences exist among viruses underlined by overlapping 
segments of lines as deteimined by the one-way analysis of variance. Least significant 
difference does not exceed 0.5797 for MAb ISU19A1,0.7933 for MAb ISU19B1, and 
0.5344 for MAb ISU25C1. Viruses without prefixes were obtained fi'om National Veterinary 
Services L aboratorics. United States Department of Agriculture, Ames, Iowa, USA. 
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Discussion 
In the present study MAbs were generated and used to fiirther characterize the 
antigenic nature of PRRS virus proteins, identify epitopes associated with neutralization and 
to increase the effectiveness of the virus marker system described in a previous study [43]. 
In that study only MAbs specific for the 5 continuous epitopes of the N protein were 
produced. No MAbs were generated to other structural proteins including envelope-
associated proteins which are of particular interest with respect to their role in mediating 
susceptibility of PRRS virus to both antibody mediated neutralization and enhancement of 
virus infection [45]. The lack of representation of other proteins by MAbs in that study was 
attributed to the highly immunodommant nature of the N protein. Consequently, the 
immunotolerizing procedure described by Matthew and Sandrock [23] was adapted in the 
present study to establish partial immunotolerance in mice to the N protein to increase the 
likelihood of generating MAbs that represented different proteins. This strategy was 
successful because only 12 of the 21 (57%) MAbs that were produced in the present study 
represented the N protein and 9 (43%) MAbs represented the envelope-associated M, GP3 
and GPS proteins. These 21 MAbs represented 3 discontinuous epitopes of both the N and M 
proteins, 3 continuous epitopes of the GPS protein and 2 continuous epitopes of the GP3 
protein. 
The identification of 3 discontinuous epitopes of the N protein in the present study 
increased the number of known discontinuous epitopes distributed among NA viruses fix>m 2 
to 4. The MAbs representing these 4 epitopes include ISUlSFd, Gd and Hd described in the 
present study, and MAb SDOW17 described by Nelson et al. [31]. The epitopes represented 
by MAbs ISUlSFd, Gd and Hd are present on all group lis viruses which include PRRS 
I l l  
viruses KY 35, ATCC VR-2332, ISU-P and the vaccine viruses RespPRRS / Repro and 
PRIME PAC PRRS (Table 1). The epitope represented by SDOW17 is present on all of 
these viruses except the vaccine virus PRIME PAC PRRS, which demonstrates its 
uniqueness [44]. Additional discontinuous epitopes may be represented by MAbs EP147 and 
V017. These MAbs have a different epitope specificity from MAb SDOW17 [31]. 
However, additional comparison of sero-reactivity patterns of MAbs ISUlSFd and Gd with 
the sero-reactivity patterns of EP147 and V017 are required to determine whether or not 
IvlAbs EP147 and V017 represent additional discontinuous epitopes among NA viruses. 
The 3 discontinuous epitopes of the M protein that were described in this study are 
the only discontinuous epitopes that have been reported for this protein to date. The 
identification of £pORF6A and B as targets for neutralizing antibody suggests that the 
domain of these epitopes is associated with the 10 to 18 amino acid portion of the M protein 
that is believed to be located on the surface of the virion and involved in receptor binding 
[36]. 
The identification of 3 continuous epitopes of the GPS protein of isolate KY 35 
increased the known number of continuous epitopes associated with this protein among NA 
viruses fi-om 3 to at least 4. These epitopes include those represented by MAbs ISU25A1 
and B1 in addition to the epitopes represented by the 2 groups of neutralizing MAbs 
described by Pirzadeh and Dea [33], i.e., MAbs IAF8A8 and 1B8 and MAbs 2A5, 3A12 and 
ICIO. A non-neutralizing MAb described by Zhang et al. [47] may represent a fifth epitope 
distributed among NA viruses or represent the same epitope as either MAb ISU25A1 or 
25B1. The neutralizing MAb ISU25C1 may represent a sixth epitope of the GPS protein or 
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represent an epitope that is detected by MAbs IAF-8A8 and IAF-1B8. All 3 of these 
neutralizing MAbs react with ATCC VR-2332 but not with the Lelystad virus. 
The identification of 2 continuous epitopes of the GP3 protein represented by MAbs 
ISU45A1 and B1 increased the known number of continuous epitopes associated with this 
protein among NA viruses from 3 to at least 5. The non-reactivity of these 2 MAbs with both 
ATCC VR-2332 and the Lelystad virus clearly demonstrates that the epitopes which they 
represent are distinct from epitopes represented by MAbs P7/al-19, P9/a3-20, and P9/b3-l 
[42] that are present in both NA viruses and the Lelystad virus. The epitopes represented by 
MAbs 1SU45A1 and B1 are also different from the epitope represented by MAb 122.14. 
This epitope was detected in the Lelystad virus and 3 NA viruses [18, 39]. Additional 
comparisons are required to determine whether MAb 122.14 is different frt)m MAbs P7/al-
19, P9/a3-20, and P9/b3-l. 
The identification of EpORF6-A and B as targets for neutralizing MAbs in the 
present study is the first report that the M protein plays a role in the susceptibility of PRRS 
virus to neutralization. Prior to the current study only the GP4 and GPS proteins had been 
identified as targets for neutralizing antibody. The role of the GPS protein as a neutralizing 
antibody-inducing protein was first demonstrated by Persch et al. [32] who raised 
neutralizing antibody in pigs inoculated with native GPS protein purified by PAGE. The role 
of the GP4 protein as a target of neutralization was demonstrated by van Nieuwstadt et al. 
[39] and Meulenberg et al. [28] who generated neutralizing MAbs that represented at least 
one distinct epitope of this protein and more recently by Weiland et al. [40] who described 2 
MAbs (P1 la/60 and PI l/d26) which may or may not represent distinct epitopes. 
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The relative importance of the GP4 and GPS proteins with respect to their ability to 
induce neutralizing antibody has been demonstrated by Gonin et al. [15]. These investigators 
compared neutralizing antibody titers of convalescent sera fiom PRRS virus-infected pigs to 
ELISA antibody titers using as antigen, recombinant N, GPS, GP4 and GPS proteins that 
were expressed in Escherichia coli. A highly significant correlation was observed between 
neutralizing titers and antibody specific for the GPS protein. No correlation was observed 
between neutralizing antibody and antibody specific for the N protein or the envelope 
associated GP3 or GP4 proteins suggesting that these proteins played a minor role in the 
induction of neutralizing antibody. The M protein was not evaluated in that study. However, 
in the present study ascitic fluid containing MAbs ISU19A1 and B1 had neutralizing titers of 
4 and 8. These relatively low titers could be an indication that the M protein like the GP4 
protein plays a minor role in the susceptibility of PRRS virus to neutralization. This 
possibility is reflected in the study by Weiland et al. [40] who generated MAb preparations 
under similar conditions with neutralizing titers ranging fi-om 80 to 1280 for MAbs 
representing the GPS protein and firom 2 to 64 for MAbs representing the GP4 protein. 
The effectiveness of the marker system described in an earlier study was markedly 
increased by the use of all of the MAbs that represented the M, GP3 and GPS proteins and 
MAb ISUlSFdl that represented one of the 3 discontinuous epitopes of the N protein (Table 
2). However, while 13 of the IS antigenic subgroups represented 1 to S of the 69 NA PRRS 
viruses each, subgroups 1 and 2 of antigenic group lis represented 17 (24.6%) and 30 
(43.S%) virxises, respectively. This disproportionately large representation of NA viruses by 
2 antigenic subgroups indicates that additional MAbs will be needed if antigenic 
characterization is to be a useful virus marker. 
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Alternatively, additional maricers such as relative sensitivity to neutralization may 
prove useful adjuncts to further categorize individual viruses within specific antigenic 
groups. The relatively wide spectrum of sensitivity of PRRS viruses to neutralization by 
MAbs ISU25C1, 19A1 and 19B1 in which significant differences (P < 0.05) were shown 
demonstrates this point (Fig. 2). This variation in susceptibihty to neutralization was not 
unexpected. A previous study by Yoon et al. [46] also demonstrated a wide range of 
susceptibility to neutralization when PRRS viruses were treated with polyclonal swine serum. 
Variation in susceptibility to neutralization could be a reflection in distribution and nimiber 
and / or accessibility of specific epitopes to neutralizing antibodies. Consequently, signature 
analysis described by Monath et al. [29] for dengue virus may also be of value in 
categorizing PRRS viruses. 
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STABILITY OF EPITOPIC PROFILES OF NORTH AMERICAN PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME 
VIRUSES DURING SERIAL PASSAGE IN PIGS 
A paper to be submitted to the Journal of General Virology 
Liuzhan Yang, Rossana Allende, Fernando A. Osorio and Kenneth B. Piatt 
Abstract 
The stability of 18 epitopes distributed among the N, M, GPS and GPS proteins of 
porcine reproductive and respiratory syndrome (PRRS) virus was evaluated by serially 
passaging 5 North American virxises in pigs in 3 separate experiments. In experiment 1,10 
pigs were inoculated intranasally with the PRRS virus 16244B and housed separately. The 
PRRS virus was isolated from tonsil biopsies of 5 pigs at 12 weeks post-inoculation (p.i.), 
and from homogenates of tonsil, lung, lung lymph nodes when 2 of these 5 pigs were killed 
at 22 weeks p.i.. In experiment 2, four groups of three pigs each were inoculated intranasally 
with PRRS viruses NVSL 6725, 14620, 46489 and 46907, respectively. Each group of 3 
pigs was housed separately. These groups of pigs were killed at 6, 7, 4 and 4 weeks p.i., 
respectively. The PRRS virus was isolated from homogenates of tonsil, lung, Ivmg lymph 
node and spleen tissues prepared from individual pigs of each group. A tissue homogenate 
from one randomly selected pig of each group was used to inociilate a second group of 3 
pigs. This protocol was repeated again for a third group of 3 pigs. Consequently, NVSL 
6725, 14620, 46489 and 46907 were serially passaged through 3 pigs for 20,21, 16 and 19 
weeks, respectively. In experiment 3, the viruses NVSL 6725 and 14620 were separately 
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serially passaged through 3 pigs essentially as described in experiment 2 with the exception 
that PRRS vims was isolated from tissue homogenates in MARC-145 cell cultures between 
pig passages. The two viruses were each serially passaged for a total of 19 weeks. No 
changes in the sero-reactivity with the panel of 18 MAbs were observed in all 5 viruses 
following in vivo passage in individual pigs. The stability of the 18 epitopes during 
maintenance and passage in pigs justifies their inclusion in an epitope-based virus marker 
system for PRRS viruses. 
Porcine reproductive and respiratory syndrome (PRRS) virus is a single-stranded, 
positive-sense RNA virus of the Arteriviridae (Cavanagh, 1997). The genome of PRRS virus 
is approximately 15 kb and consists of 8 overlapping open reading frames (ORFs) 
(Meulenberg et al., 1993). The ORFs la and lb encode nonstructural proteins associated 
with viral replicase activity (Meulenberg et al., 1993). The ORFs 2 through 7 encode 6 
structural proteins designated GP2 through GP5, M and N, respectively (Conzelmann et al., 
1993; Meulenberg et al., 1993; Meulenberg et al., 1995; Meulenberg JJM, Petersen-Den 
Besten, 1996; Van Nieuwstadt et al., 1996). The PRRS virus was first isolated by European 
investigators in 1991 and named the Leiystad virus (Wensvoort et al., 1991). A similar virus 
ATCC VR-2332 was subsequently isolated from North American swine inl992 (Benfield et 
al., 1992; Collins et al., 1992). The virus continues to be a significant economic problem for 
the swine industry. Efforts to control PRRS by vaccination and other management strategies 
have not met with consistent success. 
To better understand the epidemiology of PRRS virus, a marker system based on 18 
epitopes distributed among the N, M, GP5 and GP3 proteins has been developed and used to 
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characterize PRRS viruses (Yang et al., 1999; Yang et al., 2000a, 2000b). CurrenUy North 
American PRRS viruses can be categorized into 5 major antigenic groups representing 17 
subgroups. It is anticipated that this marker system will be expanded as additional epitopes 
are characterized. The effective and rehability of this system is dependent on the stability of 
individual epitopes of the PRRS virus in swine population. 
Recent work by Le Gall et al. (1997) suggests that an epitope can be lost or gained 
during several passages of the PRRS virus in pigs. These investigators serially passaged the 
European PRRS viruses designated I and n in pigs in 2 separate experiments. In the first 
experiment, 5 pigs were infected with virus I. Five weeks later, virus I was isolated fi-om 
each pig. The epitopic profile of virus I before and after passage was compared using a panel 
of 14 monoclonal antibodies (MAbs) representing the N, M, GP3 and GP4 proteins. No 
differences were observed in the epitopic profile of the uncloned population of virus I 
isolated from 4 of the 5 pigs. However, the uncloned population of virus I that was isolated 
from the fifth pig was serologically recognized by MAb WBE2 (Drew et al., 1995). This 
MAb recognized a continuous epitope of GP3 that was not present on virus I before passage. 
In a subsequent experiment Le Gall et al. inoculated sows at 90 days of gestation with virus 
n that is serologically recognized by MAb WBE2. The sows farrowed and 4-5 weeks later 
their pigs developed clinical signs consistent with PRRS. When these infected pigs were 17 
weeks old they were commingled with 5 contact pigs. Seven weeks later PRRS virus II was 
isolated from the serum of one of these contact pigs. No differences were observed in the 
epitopic profile of virus II following passage in pigs except the epitope represented by MAb 
WBE2 was lost. The apparent acquisition and loss of the epitope represented by MAb 
WBE2 demonstrate that changes in epitopic profile can occur within a relatively short 
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maintenance period in pigs. The loss and gain of a specific epitope suggest that mutations 
that affect epitopes can occur in some regions of the virus genome more frequently than in 
other regions. 
This possibility is supported by the observations of Rowland et al. (1999). These 
investigators extracted and sequenced viral RNA from tissues of 20 pigs ranging in age from 
0 to 132 days. These pigs were farrowed from 3 sows that were infected with the PRRS 
virus ATCC VR-2332 at 90 days of gestation. The last 312 nucleotides of ORF 4, a 10 
nucleotide untranslated region and the first 215 nucleotides of ORF 5 of the parent virus was 
compared to the homologous sequences of extracted viral RNA. A consistent nucleotide 
substitution was observed in the 215 nucleotide segment of ORF 5 in viral RNA extracted 
from lymph nodes of five 8-132 days-old pigs, thymus of one 63 days-old pig, and tonsil of 
one 10 days-old pig. No other nucleotide substitutions were found in viral RNA extracted 
from the remaining 13 pigs. 
The following study was imdertaken to determine the relative stability of 18 epitopes 
representing the N, M, GPS and GP3 proteins of 5 North American PRRS viruses. Viruses 
NVSL 6725, 14620,46489 and 46907 (KY 35) were isolated between 1989-1993 by the 
National Veterinary Services Laboratory, United States Department of Agriculture (Ames, 
Iowa). Virus NE 16244B was isolated from a pig in 1997 by the Diagnostic Laboratory at 
the University of Nebraska at Lincoln (Allende et al., 1999). These 5 viruses represented 4 
epitopic profiles as determined by their reactivity to a panel of 18 MAbs specific for the N, 
M, GPS and GP3 proteins of PRRS virus (Yang et al., 2000a, 2000b). The epitopic profiles 
of these 5 viruses are presented in Table 1. The MARC-14S cell line (Kim et al., 1993) was 
used to propagate viruses for pig inoculation and virus isolation from tissue homogenates. 
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The stability of individual epitopes represented by a panel of 18 MAbs (Table 2) was 
evaluated by comparing the epitopic profiles of each of the uncloned population of the S 
viruses before and after passage through one or more pigs in 3 separate experiments (Table 
3). The sero-reactivity of individual viruses with the panel of MAbs was determined by the 
indirect fluorescent antibody (IFA) test as described by Frey et al. (1992). In experiment 1, 
10 pigs were inoculated intranasally with 10® TCID50 of virus 16244B and housed separately 
for 22 weeks. Tonsil biopsies were collected at 12 weeks and samples of tonsil, lung and 
lung lymph nodes were collected when the pigs were killed at 22 weeks p.i. Virus was 
isolated from tonsil biopsies of all 5 pigs. Virus was also isolated from tissue homogenates 
of 2 of these 5 pigs when they were killed. 
In experiment 2, four groups of 3 pigs each were inoculated intranasally with PRRS 
viruses NVSL 6725,14620, 46489 and 46907, respectively. Each group of 3 pigs was 
housed separately. These groups of pigs were killed at 6, 7,4 and 4 weeks p.i., respectively. 
The PRRS virus was isolated from homogenates prepared from a pool of tonsil, lung, lung 
lymph node and spleen tissues collected from individual pigs of each group. A tissue 
homogenate from one pig of each group was used to inoculate a second group of 3 pigs. This 
protocol was repeated for a third group of 3 pigs. Consequently, viruses NVSL 6725, 14620, 
46489 and 46907 were maintained in pigs for a total of 20, 21, 16 and 19 weeks, 
respectively. 
Table 1. The epitopic profiles of porcine reproductive and respiratory syndrome (PRRS) viruses used in the present study 
Epitopes 
EpORF7 EpORF6 EpORFS EpORF3 
PRRS virus Antigenic 
group/subgroup* 
Al A2 Bl B2 C D E Fd Gd Hd Ad Bd Cd A B C A B 
NVSL 46907 I15/I + + + + + + + + + + + + + + + + + + 
NVSL 14620 1.5/9 + + + + + + + + + + + + - - - + + 
NVSL 46489 11,5/1 + + - - + + + + + + •f + + + + 
NVSL 6725 111,5/1 + + + - + + + •f + + -»• + + + + + + 
I6244B 1,5/1 + + + + 4- + + + + + + + + + 
* Antigenic group/subgroup of PRRS viruses are determined in the indirect immunofluorescent assay using a panel of monoclonal antibodies specific 
for the N, M, GPS and GP3 proteins (Yang et al, 2000b). Ij], III, and ni|] represent antigenic groups that are determined based on the presence or 
absence of epitopes in the N protein. The numbers I and 9 represent antigenic subgroups that are further determined based on the presence or 
absence of epitopes in the M, GPS and GP3 proteins. 
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Table 2. Characteristics of monoclonal antibodies used in the present study 
Monoclonal 
antibody Isotype Epitope 
Protein 
specificity Reference 
ISU15A1 IgGl / K  continuous N Yang et al. (1999) 
ISU15A2 IgGl / K  continuous N Yang et al. (1999) 
ISU15B1 IgGl / K  continuous N Yang et al. (1999) 
ISU15B2 IgGl/ K  continuous N Yang et al. (1999) 
ISU15C1 IgGl / K  continuous N Yang et al. (1999) 
ISU15D1 IgGl / K  continuous N 
ISU15E1 IgGl / K  continuous N 
ISUlSFdl IgGl/K discontinuous N Yang et al. (2000b) 
ISUlSGdl IgGl / K discontinuous N 
ISUlSHdl IgGl / K discontinuous N 
ISU19A1 IgGl / K  discontinuous M Yang et al. (2000b) 
ISU19B1 IgGl/ K  discontinuous M 
ISU19C1 IgGl /K  discontinuous M 
ISU25A1 IgGl / k continuous GPS Yang et al. (2000b) 
ISU25B1 IgGl / X continuous GPS 
ISU25C1 IgGl / X continuous GPS 
ISU45A1 IgGl / K  continuous GP3 Yang et al. (2000b) 
ISU45B1 IgGl/ K  continuous GP3 
In experiment 3, viruses NVSL 6725 and 14620 were separately passaged through 3 
groups of 3 pigs as described in experiment 2 with the exception that PRRS virus was 
isolated from tissue homogenates on MARC-145 cell cultures between pig passages. These 2 
viruses were maintained in pigs for a total of 19 weeks. 
No changes in the epitopic profiles were observed in imcloned populations of the 5 
viruses following passage and maintenance in pigs. These results suggest that the epitopes 
represented by the 18 MAbs are encoded by relatively stable regions of the PRRS virus 
genome and are suitable for use in the virus marker system. 
Table 3. The 3 experiments for porcine reproductive and respiratory syndrome (PRRS) virus passages in pigs 
Passage 1 Passage 2 Passage 3 
Experiment* PRRS virus 
No. of 
pigs Duration 
Virus 
recovery** 
No. of 
pigs Duration 
Virus 
recovery*" 
No. of 
pigs Duration 
Virus 
recovery*" 
1 16244B 3 
2 
12 weeks 
22 weeks 
3/3 
2/2 
2 NVSL 14620 3 7 weeks 3/3 3 7 weeks 3/3 3 7 weeks 3/3 
NVSL 6725 3 6 weeks 3/3 3 7 weeks 3/3 3 7 weeks 3/3 
NVSL 46489 3 4 weeks 3/3 3 6 weeks 3/3 3 6 weeks 3/3 
NVSL 46907 3 4 weeks 3/3 3 7 weeks 3/3 3 7 weeks 3/3 
3 NVSL 14620 3 5 weeks 3/3 3 7 weeks 3/3 3 7 weeks 3/3 
NVSL 6725 3 6 weeks 3/3 3 7 weeks 3/3 3 6 weeks 3/3 
'The S PRRS viruses were passaged in 3 separate experiments. In experiment I, the virus 16244B was inoculated into S pigs. Tonsil biopsies were 
collected at 12 weeks post-infection from these 10 pigs. Tissue samples of tonsils, lungs, lung lymph nodes were collected from these pigs when they 
were killed at 22 weeks post-infection. In experiment 2, each of viruses (NVSL 6725,14620,46489 and 46907) was inoculated into 3 pigs. Pigs were 
killed at 4-7 weeks post-infection. Homogenate of tonsil, lung, lung lymph node and spleen from one pig at the end of each passage was inoculated into 
3 additional pigs. Iltese 4 viruses were consecutively passaged 3 times in pigs for a total of 16-21 weeks. In experiment 3,2 viruses (NVSL 6725 and 
14620) were passaged similar experiment 2 with the except that the viruses were propagated once on MARC-145 cells before next passage. Two ml of 
propagated viruses was inoculated into 3 additional pigs. 
** Viruses were recovered from pooled homogenates of tonsil, lung and lung lymph node in experiment 1, and from pooled homogenates of tonsil, lung, 
lung lymph node and spleen in experiments 2 and 3. 
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GENERAL CONCLUSIONS 
General Summary 
This research focused on the development of an epitope-based marker system for use 
in categorizing porcine reproductive and respiratory syndrome (PRRS) viruses. Three papers 
are presented as Chapters 2, 3 and 4 in this dissertation. Chapter 2 described the generation 
and characterization of a panel of 24 murine monoclonal antibodies specific for the N protein 
of the North American virus ISU-P (ATCC VR-2402), and the categorization of PRRS 
viruses. Five continuous epitopes designated EpORF7-A through E were revealed in the N 
protein by the sero-reactivity pattern of these MAbs with 67 North American field viruses, 
two modified-live vaccine viruses, and the European Lelystad virus as determined by the 
indirect immunofluorescence assay and Westem immimoblotting and confirmed by additivity 
and blocking enzyme-linked immunosorbent assays. The sero-reactivity pattern of Noith 
American viruses in the IFA enabled their subdivision into 4 antigenic groups which 
represented 84.1, 11.6, 2.9 and 1.4% of viruses tested. The antigenic variation among these 
viruses was correlated to single, group-specific nucleotide substitutions and mediated by a 
combination of at least 4 of the 5 epitopes. EpORF7-A was conserved in all North American 
viruses and the Lelystad virus which constituted a separate antigenic group. Consequently, 
monoclonal antibodies specific for EpORF7-A may prove useful as the antigenic basis for a 
imiversal diagnostic test for the PRRS virus. EpORF7-C, D and E were only present in the 
North American viruses tested. 
Chapter 3 described the expansion of the MAb panel and further categorization of 
PRRS viruses. Eleven epitopes were identified by murine MAbs that represented the N, M, 
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GPS and GP3 proteins of the North American PRRS vims, KY 3S (NVSL 46907). Three 
discontinuous epitopes of the N and M proteins were designated EpORF7-Fd through Hd and 
EpORF6-Ad through Cd. Five continuous epitopes of the GPS and GP3 proteins were 
designated EpORF5-A through C and EpORF3-A and B. The MAbs representing EpORFS-
C and EpORF6-A and B had neutralizing activity. The MAbs representing the above 
epitopes, except EpORF7-Gd and Hd, expanded the virus marker system described in 
Chapter 2 in which a panel of 69 North American viruses and the Leiystad virus were 
categorized into S antigenic groups, I15 through V15 based on the presence or absence of 5 
continuous epitopes of the N protein. Antigenic groups I15 and II15, which represented 84.7 
and 11.6% of all viruses tested, were categorized further into 9 and 4 subgroups, respectively. 
The remaining North American viruses and the Leiystad virus were distributed among 4 
groups, one of which was represented by 2 subgroups. Significant (P < 0.05) differences in 
sensitivity to neutralization of 28 viruses representing 6 antigenic groups by the 3 
neutralizing MAbs suggested that sensitivity to neutralization may also be of value in 
categorizing PRRS viruses. 
Chapter 4 described the evaluation of the stability of epitopic profiles collectively 
representing 18 epitopes distributed among the N, M, GPS and GP3 proteins of PRRS viruses 
by serially passaging S North American viruses in pigs in 3 separate experiments. In 
experiment 1, 5 pigs were inoculated intranasally with the PRRS virus NE 16244B and 
housed separately. The PRRS virus was isolated fix)m tonsil tissues firom 3 pigs that were 
killed at 12 weeks post-inoculation (p.i.), and fi'om tonsil biopsies of 2 of these S pigs at 12 
weeks p.i. and again firom tonsil tissues when these pigs were killed at 22 weeks p.i.. In 
experiment 2, four groups of three pigs each were separately inoculated intranasaly with 
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PRRS viruses NVSL 6725,14620, 46489 and 46907. Each group of 3 pigs was housed 
separately. Individual groups of pigs were killed at 6, 7,4 and 4 weeks p.i., respectively. 
The PRRS virus was isolated from homogenates consisting of tonsil, lymph node, lung and 
spleen tissues prepared from individual pigs of each group. A tissue homogenate from one 
pig of each group was used to inoculate a second group of 3 pigs. This protocol was repeated 
again for a third group of 3 pigs. Consequently, viruses NVSL 6725, 14620,46489 and 
46907 were maintained in pigs for 20, 21,16 and 19 weeks, respectively. In experiment 3, 
the viruses NVSL 6725 and 14620 were serially passaged separately through 3 pigs 
essentially as described in experiment 2, with the exception that the PRRS virus was isolated 
from tissue homogenates in MARC-145 cell cultures between pig passages. The two viruses 
were each maintained in pigs for a total of 19 weeks. No changes were observed in the sero-
reactivity of these 5 viruses with the panel of 18 MAbs following maintenance in individual 
pigs for periods up to 22 weeks in experiment 1, 16-21 weeks in experiment 2, and 19 weeks 
in experiment 3. The stability of sero-reactivity patterns of these viruses demonstrates that 
an epitopic profile-based virus maricer system to characterize PRRS viruses can be used with 
reliability in epidemiological studies. 
General Discussion 
Development of a virus marker system 
The principal objectives of the current study were to characterize the antigenic nature 
of PRRS virus proteins, to identify epitopes associated with neutralization activity and to 
develop a marker system for epidemiological studies of PRRS viruses. In the study 
described in Chapter 2, only MAbs specific for the 5 continuous epitopes of the N protein 
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were produced. No MAbs were generated to other structural proteins including envelope-
associated proteins which are of particular interest with respect to their role in mediating 
susceptibility of PRRS virus to both antibody mediated neutralization and enhancement of 
virus infection. The lack of representation of other proteins by MAbs in that study was 
attributed to the highly inmiunodominant nature of the N protein. Consequently, the 
immunotolerizing procedure described by Matthew and Sandrock (1987) was used as 
described in Chapter 3 to establish partial immunotolerance in mice to the N protein to 
increase the likelihood of generating MAbs that represented different proteins. This strategy 
was successful because only 12 of the 21 (57%) MAbs that were produced represented the N 
protein and 9 (43%) MAbs represented the envelope-associated M, GP3 and GPS proteins. 
These 21 MAbs represented 3 discontinuous epitopes of both the N and M proteins, 3 
continuous epitopes of the GPS protein and 2 continuous epitopes of the GP3 protein. The 
generation of a large panel of MAbs specific for continuous and discontinuous epitopes on 
the N, M GPS and GP3 proteins has made it possible to develop a virus marker system to 
categorize PRRS viruses into unique antigenic groups. 
N protein 
Published data prior to the present study suggest that at least 5 epitopes in various 
combinations are associated with the N protein of North American and European PRRS 
viruses. Three of these epitopes are most likely discontinuous because of their inability to be 
recognized by these MAbs in Western immunoblotting. These epitopes are represented by 
MAbs SDOW 17, VO 17 (Nelson et al., 1993) and ICHS (Rodriguez et al., 1997). The 
monoclonal antibodies SDOW 17 and VO 17 represent 2 distinctly different conserved 
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epitopes. The origmal characterization of MAbs SDOW 17 and VO 17 by Nelson et al. 
(1993) demonstrated that MAb SDOW 17 reacted with all 63 North American and 57 
European viruses tested. In contrast, MAb VO 17 only recognized North American viruses. 
The monoclonal antibody ICH5 appears to be different from MAb SDOW 17 because it 
failed to react in the EFA with 3 North American viruses (Le Gall et al., 1997). The 2 
continuous epitopes are represented by MAbs WBE 1 and WBE 4 respectively (Drew et al., 
1995). Their distinctness was demonstrated by their reactivity pattern with a combined total 
of 44 European and 11 North American PRRS viruses (Drew et al., 1995; Le Gall et al., 
1997). Both MAbs reacted with all European viruses tested but while MAb WBE 4 did not 
react with any of the 11 North American viruses, MAb WBE 1 reacted with 3. 
In addition to the 5 epitopes described above, a sixth epitope specific for the N 
protein may also exist. It is continuous and is represented by MAb P3/27 that was originally 
shown to react with all 14 European and 12 North American viruses tested (Wieczorek-
Krohmer et al., 1996). In another study (Le Gall et al., 1997), MAb P3/27 was shown to 
have the same IFA reactivity pattem as MAb WBE 1. In that smdy, both MAbs reacted with 
all 21 European and 3 North American viruses tested. There are no published accounts that 
clearly indicate whether or not MAb P3/27 reacts with the 8 North American viruses that 
were not recognized by WBE I (Drew et al., 1995) or that WBE 1 reacts with the 12 North 
American viruses recognized by P3/27 (Wieczorek-Krohmer et al., 1996). Consequently, it 
remains to be clarified whether or not MAbs P3/27 and WBE 1 represent the same or 
different epitopes. Nevertheless, the two published accounts which indicate that MAb P3/27 
reacted with 15 of 15 North American viruses tested (Le Gall et al., 1997; Wieczorek-
135 
Krohmer et al., 1996) and that MAb WBE 1 did not react with 8 different North American 
viruses (Drew et al., 1995) suggest that the 2 MAbs represent different epitopes. 
In the present study, 5 distinct continuous epitopes designated EpORF7-A through E 
were revealed among North American viruses further contributing to our knowledge of the 
antigenic nature of the N protein of PRRS virus. The uniqueness of the individual epitopes 
was confirmed by the results of blocking and additivity ELISA assays. In the blocking assay 
(see Chapter 2, Table 4), heterologous MAbs failed to inhibit binding of MAbs representing 
each of the 5 different epitopes (p < 0.001). While in the additivity assay (see Ch^ter 2, 
Table 3) the optical density measured following treatment of antigen preparations with MAb 
representing each epitope was significantly enhanced (p < 0.001) after additional treatment 
with heterologous MAbs but not with homologous MAbs. At least 4 of the 5 continuous 
epitopes were present in all viruses tested with the exception of the Lelystad virus that 
contained only EpORF7-A as determined by both IFA and Western immunoblotting (see 
Chapter 2, Table 2). Consequently, it is possible that EpORF7-A may represent the same 
epitope as P3/27. Analysis of a broad panel of European PRRS viruses will be necessary to 
determine which if any of the remaining 4 continuous epitopes are present in European 
viruses. 
The identification of 3 discontinuous epitopes of the N protein in the present study 
increased the number of known discontinuous epitopes distributed among North American 
viruses firom 2 to 4. The monoclonal antibodies representing these 4 discontinuous epitopes 
include ISUlSFd, Gd and Hd described in the present study, and MAb SDOW17 described 
by Nelson et al. (1993). The epitopes represented by MAbs ISU15Fd, Gd and Hd are present 
on all group Ijs viruses which include PRRS viruses KY 35, ATCC VR-2332, ISU-P and the 
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vaccine viruses RespPRRS/Repro and PRIME PAC PRRS (see Chapter 3, Table 1). The 
epitope represented by SDOWl 7 is present on all of these viruses except the vaccine virus 
PRIME PAC PRRS, which demonstrates its uniqueness (impublished data, Yang & Piatt, 
2000). Additional discontinuous epitopes may be represented by MAbs EP147 and V017. 
These MAbs have a different epitope specificity from MAb SDOW17 (Nelson et al., 1993). 
However, additional comparisons of sero-reactivity patterns of MAbs ISUlSFd and Gd with 
the sero-reactivity patterns of EP147 and V017 are required to determine whether or not 
MAbs EP147 and V017 represent additional discontinuous epitopes among North American 
viruses. 
The degree of antigenic diversity demonstrated among North American viruses in the 
present study was less than expected. The distribution of the S continuous and 3 
discontinuous epitopes associated with the N protein of North American PRRS viruses 
permitted their subdivision into S antigenic groups that were distinctly different from the 
European Lelystad virus. However, antigenic groups I and n represented 82.6% and 11.6% 
of all viruses tested while groups HI, IV and VI represented the remaining 5.8% of the 
viruses. This limited antigenic diversity among North American PRRS viruses as revealed 
by the panel of MAbs specific for the N protein indicated that a usefiil marker system would 
require a broader panel of MAbs representing epitopes of other PRRS virus proteins. 
Consequently, MAbs representing the M, GP3 and GPS proteins were generated and 
incorporated into the marker system. 
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M protein 
The 3 discontinuous epitopes of the M protein that were described in this study are 
the only discontinuous epitopes that have been reported for this protein to date. The 
identification of EpORF6Ad and Bd as targets for neutralizing antibody suggests that the 
domain of these epitopes is associated with the 10 to 18 amino acid portion of the M protein 
that is believed to be located on the surface of the virion and involved in receptor binding 
(Snijder and Meulenberg, 1998). 
GPS protein 
The identification of 3 continuous epitopes of the GPS protein of the virus KY 35 
increased the known number of continuous epitopes associated with this protein among 
North American viruses firom 3 to at least 4. These epitopes include those represented by 
MAbs ISU25A1 and B1 in addition to the epitopes represented by the 2 groups of 
neutralizing MAbs described by Pirzadeh and Dea (1996), i.e. MAbs IAF8A8 and IBS and 
MAbs 2A5, 3A12 and ICIO. A non-neutralizing MAb described by Zhang et al. (1998) may 
represent a fifth epitope distributed among North American viruses or represent the same 
epitope as either MAb ISU25A1 or 25B1. The neutralizing MAb ISU25C1 may represent a 
sixth epitope of the GPS protein or represent an epitope that is detected by MAbs IAF-8A8 
and IAF-1B8. All 3 of these neutralizing MAbs react with ATCC VR-2332 but not with the 
Leiystad virus. 
GPS protein 
The identification of 2 continuous epitopes of the GP3 protein represented by MAbs 
ISU45A1 and B1 increased the known number of continuous epitopes associated with this 
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protein among North American viruses from 3 to at least 5. The non-reactivity of these 2 
MAbs with both ATCC VR-2332 and the Lelystad virus clearly demonstrates that the 
epitopes which they represent are distinct from epitopes represented by MAbs P7/al-19, 
P9/a3-20, and P9/b3-l (Wieczorek-Krohmer et al., 1996) that are present in both North 
American viruses and the Lelystad virus. The epitopes represented by MAbs ISU45A1 and 
B1 are also different from the epitope represented by MAb 122.14. This epitope was 
detected in the Lelystad virus and 3 North American viruses (Le Gall et al., 1997; Van 
Nieuwstadt et al., 1996). Additional comparisons are required to determine whether MAb 
122.14 is different from MAbs P7/al-19, P9/a3-20, and P9/b3-l. 
The effectiveness of the marker system described in the Ch^ters 2 and 3 was 
markedly increased by the use of all of the MAbs that represented the N, M, GP3 and GPS 
proteins. Sixty-nine North American PRRS viruses could be categorized into 5 antigenic 
groups which represented 17 subgroups (Chapter 3, Table 2). However, while 13 of the 15 
antigenic subgroups represented 1 to 5 of the 69 North American PRRS viruses each, 
subgroups 1 and 2 of antigenic group lis represented 17 (24.6%) and 30 (43.5%) viruses, 
respectively. This disproportionately large representation of North American viruses by 2 
antigenic subgroups indicates that additional MAbs are needed to increase the efficiency of 
this marker system. In addition, it may be possible to further differentiate subgroups of these 
viruses by their susceptibility to neutralization. The potential usefulness of susceptibility of 
virus to neutralization to further characterize viruses was demonstrated in the present study 
(see Chapter 3, Figure 2). Significant (P<0.05) differences in sensitivity to neutralization of 
28 viruses representing 6 antigenic groups were observed when viruses were treated with 
MAbs ISU19A1, B1 and ISU25C1. 
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Stability of epitopic profiles during passage in pigs 
The effectiveness and reliability of the virus marker system developed in this study is 
dependent on the stability of individual epitopes of the PRRS virus in swine population. 
Recent work by Le Gall et al. (1997) suggests that an epitope can be lost or gained during 
several passages of the PRRS virus in pigs. These investigators serially passaged the 
European PRRS viruses designated I and n in pigs in 2 separate experiments. They found 
that virus I gained an epitope in GP3 that was represented by MAb WBE2 (Drew et al., 
1995) while virus n lost the same epitope following maintenance in pigs for periods of 5 and 
27 weeks, respectively. The loss and gain of a specific epitope suggest that mutations that 
affect epitopes can occur in some regions of the virus genome more frequently than in other 
regions. This possibility is supported by the observations of Rowland et al. (1999). These 
investigators observed a consistent nucleotide substitution at position 100 in the first 215 
nucleotide segment of ORF 5 in viral RNA firom tissues of 20 pigs ranging in age fi'om 0 to 
132 days. These pigs were farrowed fi-om 3 sows that were infected 3 sows with the PRRS 
virus ATCC VR-2332 at 90 days of gestation. No other nucleotide substitutions were foimd 
in the last 312 nucleotides of ORF 4 and a 10 nucleotide untranslated region in viral RNA 
extracted fi-om the remaining 13 pigs. 
The study presented in Chapter 4 demonstrated that 5 North American PRRS viruses 
maintained their epitopic profiles following several passages in pigs for periods up to 22 
weeks. These 2 experiments simulated field conditions. In experiment 3, virus propagation 
in MARC-145 cells between pig passages had no effect on the epitopes of 2 viruses (NVSL 
6725 and 14620). The maintenance period of epitopic profiles included viremic and 
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persistent phases. Results obtained fix)in the present study also justify the incorporation of 
the epitopes represented by the 18 MAbs in the virus marker system. 
Ideatificatioa of nucleotide sequences that encode specific epitopes of PRRS virus 
proteins 
In an effort to determine the approximate locations of EpORF7-A through E in the N 
protein, the deduced amino acid sequences were computer analyzed using the GCG package. 
None of the parameters as described in the Materials and Methods section of Chapter 2 could 
be correlated to antigenic sites with the possible exception of Chou-Fasman (CF) profiles, as 
indicated by nimiber, location, shape and size of CF turns. Individual CF turns are a 
reflection of secondary structure which can influence antigenicity. Unique differences in the 
CF profiles of antigenic groups n, HI and IV relative to the CF profile of group I were 
observed at locations encompassing amino acids 120, 122 and 70 respectively (see Ch^ter 2, 
Figure 5). These amino acids represent imique group specific substitutions that appear to be 
correlated to the absence of EpORF7-B, C and D in antigenic groups n, HI and FV, 
respectively. This observation and the demonstration of inhibition mediated by MAbs 
representing EpORF7-E with MAbs representing EpORF7-B, C and D (see Chapter 2, Figure 
2) suggest that the amino acid sequences representing EpORF7-B, C and D are relatively 
close to one another at the carboxyl terminal end of the N protein. The absence of reciprocal 
or one-way inhibition between MAbs representing EpORF7-A and EpORF7-B, C, D and E 
in the blocking assay (see Chapter 2, Table 4) suggests that EpORF7-A is spatially distant 
from these epitopes. 
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The available data are not sufficient to predict the probable location of EpORF7-A or 
E. However, a recent study by Rodriguez et al. (1997) demonstrated the presence of a 
continuous epitope in the central region of the N protein in both a European (Olot/91) and a 
North American (Quebec 807/94) PRRS virus by reacting a panel of MAbs with fragments of 
recombinant N protein by Western immunoblotting. They further demonstrated that a highly 
conserved amino acid sequence extended from amino acid 50-90 in the N protein of 3 North 
American and 2 European viruses that included the Lelystad virus. Amino acids 50-66 were 
associated with the common epitope. These observations suggest that the common epitope 
described by Rodriguez et al. could be identical to EpORF7-A. Competitive assays between 
MAbs representing EpORF7-A and the common epitope described by Rodriguez et al. 
(1997) may answer this question. 
The inability to conclusively identity the location of specific epitopes by comparing 
amino acid substitutions of different viruses in the present study suggests that the approach 
used by Rodriguez et al. (1997) for the purpose has been more productive. Site-directed 
mutagenesis or synthesis of a series of protein fragments could be possible altemative 
methods. 
Future Studies 
In the present study a virus marker system was developed based on the presence and 
absence of 18 epitopes. As a result. North American PRRS viruses could be categorized into 
5 antigenic groups representing 17 subgroups. However, 68.1% of all viruses tested were 
represented by only 2 subgroups. Consequently, there is a need to develop additional MAbs, 
especially to the M, GP2 through GPS proteins to further difiTerentiate these virtises. The use 
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of additional markers such as susceptibility to neutralization and signature analysis (Monath 
et al., 1986) should be included for this purpose. 
This marker system will be used in epidemiological studies of PRRS viruses to 
determine if success or failure of control programs can be correlated with specific antigenic 
groups of PRRS viruses. In addition, the MAbs characterized in this study should also be 
used to identify epitopes in the N, M, GP3 and GPS proteins associated with pathogenesis, 
antibody-dependent enhancement of PRRS virus the infection and induction of protective 
immunity. The generation of this information will be valuable in the development of more 
effective vaccines. 
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